Motif 903 (n=81)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
C9J798 | RASA4B | S760 | ochoa | Ras GTPase-activating protein 4B | Ca(2+)-dependent Ras GTPase-activating protein, that may play a role in the Ras-MAPK pathway. {ECO:0000250|UniProtKB:O43374}. |
O00257 | CBX4 | S291 | ochoa | E3 SUMO-protein ligase CBX4 (EC 2.3.2.-) (Chromobox protein homolog 4) (Polycomb 2 homolog) (Pc2) (hPc2) | E3 SUMO-protein ligase that catalyzes sumoylation of target proteins by promoting the transfer of SUMO from the E2 enzyme to the substrate (PubMed:12679040, PubMed:22825850). Involved in the sumoylation of HNRNPK, a p53/TP53 transcriptional coactivator, hence indirectly regulates p53/TP53 transcriptional activation resulting in p21/CDKN1A expression. Monosumoylates ZNF131 (PubMed:22825850). {ECO:0000269|PubMed:12679040, ECO:0000269|PubMed:22825850}.; FUNCTION: Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development (PubMed:12167701, PubMed:19636380, PubMed:21282530). PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:12167701, PubMed:19636380, PubMed:21282530). Binds to histone H3 trimethylated at 'Lys-9' (H3K9me3) (By similarity). Plays a role in the lineage differentiation of the germ layers in embryonic development (By similarity). {ECO:0000250|UniProtKB:O55187, ECO:0000269|PubMed:12167701, ECO:0000269|PubMed:19636380, ECO:0000269|PubMed:21282530}. |
O43374 | RASA4 | S760 | ochoa | Ras GTPase-activating protein 4 (Calcium-promoted Ras inactivator) (Ras p21 protein activator 4) (RasGAP-activating-like protein 2) | Ca(2+)-dependent Ras GTPase-activating protein, that switches off the Ras-MAPK pathway following a stimulus that elevates intracellular calcium. Functions as an adaptor for Cdc42 and Rac1 during FcR-mediated phagocytosis. {ECO:0000269|PubMed:11448776}. |
P0DMV8 | HSPA1A | S418 | ochoa|psp | Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70-1) (HSP70.1) (Heat shock protein family A member 1A) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:24318877, PubMed:26865365). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). Required as a co-chaperone for optimal STUB1/CHIP ubiquitination of NFATC3 (By similarity). Negatively regulates heat shock-induced HSF1 transcriptional activity during the attenuation and recovery phase period of the heat shock response (PubMed:9499401). Involved in the clearance of misfolded PRDM1/Blimp-1 proteins. Sequesters them in the cytoplasm and promotes their association with SYNV1/HRD1, leading to proteasomal degradation (PubMed:28842558). {ECO:0000250|UniProtKB:P0DMW0, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000269|PubMed:28842558, ECO:0000269|PubMed:9499401, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}. |
P0DMV9 | HSPA1B | S418 | ochoa | Heat shock 70 kDa protein 1B (Heat shock 70 kDa protein 2) (HSP70-2) (HSP70.2) (Heat shock protein family A member 1B) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:24318877, PubMed:26865365). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). {ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}. |
P11217 | PYGM | S789 | ochoa | Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase) | Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis. {ECO:0000269|PubMed:8316268}. |
P13569 | CFTR | S753 | psp | Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel) | Epithelial ion channel that plays an important role in the regulation of epithelial ion and water transport and fluid homeostasis (PubMed:26823428). Mediates the transport of chloride ions across the cell membrane (PubMed:10792060, PubMed:11524016, PubMed:11707463, PubMed:12519745, PubMed:12529365, PubMed:12588899, PubMed:12727866, PubMed:15010471, PubMed:17036051, PubMed:1712898, PubMed:17182731, PubMed:19398555, PubMed:19621064, PubMed:22178883, PubMed:25330774, PubMed:26846474, PubMed:28087700, PubMed:8910473, PubMed:9804160). Possesses an intrinsic ATPase activity and utilizes ATP to gate its channel; the passive flow of anions through the channel is gated by cycles of ATP binding and hydrolysis by the ATP-binding domains (PubMed:11524016, PubMed:15284228, PubMed:26627831, PubMed:8910473). The ion channel is also permeable to HCO(3)(-); selectivity depends on the extracellular chloride concentration (PubMed:15010471, PubMed:19019741). In vitro, mediates ATP-dependent glutathione flux (PubMed:12727866). Exerts its function also by modulating the activity of other ion channels and transporters (PubMed:12403779, PubMed:22121115, PubMed:22178883, PubMed:27941075). Plays an important role in airway fluid homeostasis (PubMed:16645176, PubMed:19621064, PubMed:26823428). Contributes to the regulation of the pH and the ion content of the airway surface fluid layer and thereby plays an important role in defense against pathogens (PubMed:14668433, PubMed:16645176, PubMed:26823428). Modulates the activity of the epithelial sodium channel (ENaC) complex, in part by regulating the cell surface expression of the ENaC complex (PubMed:17182731, PubMed:17434346, PubMed:27941075). Inhibits the activity of the ENaC channel containing subunits SCNN1A, SCNN1B and SCNN1G (PubMed:17182731). Inhibits the activity of the ENaC channel containing subunits SCNN1D, SCNN1B and SCNN1G, but not of the ENaC channel containing subunits SCNN1A, SCNN1B and SCNN1G (PubMed:17182731, PubMed:27941075). May regulate bicarbonate secretion and salvage in epithelial cells by regulating the transporter SLC4A7 (PubMed:12403779). Can inhibit the chloride channel activity of ANO1 (PubMed:22178883). Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation (PubMed:19923167, PubMed:27714810, PubMed:29393851). {ECO:0000269|PubMed:10792060, ECO:0000269|PubMed:11524016, ECO:0000269|PubMed:11707463, ECO:0000269|PubMed:12403779, ECO:0000269|PubMed:12519745, ECO:0000269|PubMed:12529365, ECO:0000269|PubMed:12588899, ECO:0000269|PubMed:12727866, ECO:0000269|PubMed:14668433, ECO:0000269|PubMed:15010471, ECO:0000269|PubMed:15284228, ECO:0000269|PubMed:16645176, ECO:0000269|PubMed:17036051, ECO:0000269|PubMed:1712898, ECO:0000269|PubMed:17182731, ECO:0000269|PubMed:19019741, ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:19621064, ECO:0000269|PubMed:22178883, ECO:0000269|PubMed:25330774, ECO:0000269|PubMed:26627831, ECO:0000269|PubMed:26823428, ECO:0000269|PubMed:26846474, ECO:0000269|PubMed:27714810, ECO:0000269|PubMed:27941075, ECO:0000269|PubMed:28087700, ECO:0000269|PubMed:29393851, ECO:0000269|PubMed:8910473, ECO:0000269|PubMed:9804160, ECO:0000305|PubMed:19923167}. |
P15822 | HIVEP1 | S637 | ochoa | Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1) | This protein specifically binds to the DNA sequence 5'-GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV-1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, and interferon-beta genes. It may act in T-cell activation. Involved in activating HIV-1 gene expression. Isoform 2 and isoform 3 also bind to the IPCS (IRF1 and p53 common sequence) DNA sequence in the promoter region of interferon regulatory factor 1 and p53 genes and are involved in transcription regulation of these genes. Isoform 2 does not activate HIV-1 gene expression. Isoform 2 and isoform 3 may be involved in apoptosis. |
P16615 | ATP2A2 | S608 | ochoa | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) | This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen (PubMed:12542527, PubMed:16402920). Involved in autophagy in response to starvation. Upon interaction with VMP1 and activation, controls ER-isolation membrane contacts for autophagosome formation (PubMed:28890335). Also modulates ER contacts with lipid droplets, mitochondria and endosomes (PubMed:28890335). In coordination with FLVCR2 mediates heme-stimulated switching from mitochondrial ATP synthesis to thermogenesis (By similarity). {ECO:0000250|UniProtKB:O55143, ECO:0000269|PubMed:12542527, ECO:0000269|PubMed:16402920, ECO:0000269|PubMed:28890335}.; FUNCTION: [Isoform 2]: Involved in the regulation of the contraction/relaxation cycle. Acts as a regulator of TNFSF11-mediated Ca(2+) signaling pathways via its interaction with TMEM64 which is critical for the TNFSF11-induced CREB1 activation and mitochondrial ROS generation necessary for proper osteoclast generation. Association between TMEM64 and SERCA2 in the ER leads to cytosolic Ca(2+) spiking for activation of NFATC1 and production of mitochondrial ROS, thereby triggering Ca(2+) signaling cascades that promote osteoclast differentiation and activation. {ECO:0000250|UniProtKB:O55143}. |
P19021 | PAM | S929 | ochoa | Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)] | Bifunctional enzyme that catalyzes amidation of the C-terminus of proteins (PubMed:12699694, PubMed:2357221). Alpha-amidation is present at the C-terminus of many endocrine hormones and neuropeptides and is required for their activity (PubMed:1575450). C-terminal amidation also takes place in response to protein fragmentation triggered by oxidative stress, promoting degradation of amidated protein fragments by the proteasome (PubMed:2207077). Alpha-amidation involves two sequential reactions, both of which are catalyzed by separate catalytic domains of the enzyme (PubMed:12699694). The first step, catalyzed by peptidyl alpha-hydroxylating monooxygenase (PHM) domain, is the copper-, ascorbate-, and O2- dependent stereospecific hydroxylation (with S stereochemistry) at the alpha-carbon (C-alpha) of the C-terminal glycine of the peptidylglycine substrate (PubMed:12699694). The second step, catalyzed by the peptidylglycine amidoglycolate lyase (PAL) domain, is the zinc-dependent cleavage of the N-C-alpha bond, producing the alpha-amidated peptide and glyoxylate (PubMed:12699694). Similarly, catalyzes the two-step conversion of an N-fatty acylglycine to a primary fatty acid amide and glyoxylate (By similarity). {ECO:0000250|UniProtKB:P14925, ECO:0000269|PubMed:12699694, ECO:0000269|PubMed:2357221, ECO:0000303|PubMed:1575450, ECO:0000303|PubMed:2207077}. |
P23327 | HRC | S285 | ochoa | Sarcoplasmic reticulum histidine-rich calcium-binding protein | May play a role in the regulation of calcium sequestration or release in the SR of skeletal and cardiac muscle. |
P23921 | RRM1 | S119 | ochoa | Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) | Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. |
P26038 | MSN | S536 | ochoa | Moesin (Membrane-organizing extension spike protein) | Ezrin-radixin-moesin (ERM) family protein that connects the actin cytoskeleton to the plasma membrane and thereby regulates the structure and function of specific domains of the cell cortex. Tethers actin filaments by oscillating between a resting and an activated state providing transient interactions between moesin and the actin cytoskeleton (PubMed:10212266). Once phosphorylated on its C-terminal threonine, moesin is activated leading to interaction with F-actin and cytoskeletal rearrangement (PubMed:10212266). These rearrangements regulate many cellular processes, including cell shape determination, membrane transport, and signal transduction (PubMed:12387735, PubMed:15039356). The role of moesin is particularly important in immunity acting on both T and B-cells homeostasis and self-tolerance, regulating lymphocyte egress from lymphoid organs (PubMed:9298994, PubMed:9616160). Modulates phagolysosomal biogenesis in macrophages (By similarity). Also participates in immunologic synapse formation (PubMed:27405666). {ECO:0000250|UniProtKB:P26041, ECO:0000269|PubMed:10212266, ECO:0000269|PubMed:12387735, ECO:0000269|PubMed:15039356, ECO:0000269|PubMed:27405666, ECO:0000269|PubMed:9298994, ECO:0000269|PubMed:9616160}. |
P29597 | TYK2 | S431 | ochoa | Non-receptor tyrosine-protein kinase TYK2 (EC 2.7.10.2) | Tyrosine kinase of the non-receptor type involved in numerous cytokines and interferons signaling, which regulates cell growth, development, cell migration, innate and adaptive immunity (PubMed:10542297, PubMed:10995743, PubMed:7657660, PubMed:7813427, PubMed:8232552). Plays both structural and catalytic roles in numerous interleukins and interferons (IFN-alpha/beta) signaling (PubMed:10542297). Associates with heterodimeric cytokine receptor complexes and activates STAT family members including STAT1, STAT3, STAT4 or STAT6 (PubMed:10542297, PubMed:7638186). The heterodimeric cytokine receptor complexes are composed of (1) a TYK2-associated receptor chain (IFNAR1, IL12RB1, IL10RB or IL13RA1), and (2) a second receptor chain associated either with JAK1 or JAK2 (PubMed:10542297, PubMed:25762719, PubMed:7526154, PubMed:7813427). In response to cytokine-binding to receptors, phosphorylates and activates receptors (IFNAR1, IL12RB1, IL10RB or IL13RA1), creating docking sites for STAT members (PubMed:7526154, PubMed:7657660). In turn, recruited STATs are phosphorylated by TYK2 (or JAK1/JAK2 on the second receptor chain), form homo- and heterodimers, translocate to the nucleus, and regulate cytokine/growth factor responsive genes (PubMed:10542297, PubMed:25762719, PubMed:7657660). Negatively regulates STAT3 activity by promototing phosphorylation at a specific tyrosine that differs from the site used for signaling (PubMed:29162862). {ECO:0000269|PubMed:10542297, ECO:0000269|PubMed:10995743, ECO:0000269|PubMed:25762719, ECO:0000269|PubMed:29162862, ECO:0000269|PubMed:7526154, ECO:0000269|PubMed:7638186, ECO:0000269|PubMed:7657660, ECO:0000269|PubMed:7813427, ECO:0000269|PubMed:8232552}. |
P31930 | UQCRC1 | S159 | ochoa | Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1) | Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. The cytochrome b-c1 complex catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to translocation of protons across the mitochondrial inner membrane, with protons being carried across the membrane as hydrogens on the quinol. In the process called Q cycle, 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space and 2 electrons are passed to cytochrome c (By similarity). The 2 core subunits UQCRC1/QCR1 and UQCRC2/QCR2 are homologous to the 2 mitochondrial-processing peptidase (MPP) subunits beta-MPP and alpha-MPP respectively, and they seem to have preserved their MPP processing properties (By similarity). May be involved in the in situ processing of UQCRFS1 into the mature Rieske protein and its mitochondrial targeting sequence (MTS)/subunit 9 when incorporated into complex III (Probable). Seems to play an important role in the maintenance of proper mitochondrial function in nigral dopaminergic neurons (PubMed:33141179). {ECO:0000250|UniProtKB:P07256, ECO:0000250|UniProtKB:P31800, ECO:0000269|PubMed:33141179, ECO:0000305|PubMed:29243944}. |
P34931 | HSPA1L | S420 | ochoa | Heat shock 70 kDa protein 1-like (Heat shock 70 kDa protein 1L) (Heat shock 70 kDa protein 1-Hom) (HSP70-Hom) (Heat shock protein family A member 1L) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). Positive regulator of PRKN translocation to damaged mitochondria (PubMed:24270810). {ECO:0000269|PubMed:24270810, ECO:0000303|PubMed:26865365}. |
P37235 | HPCAL1 | S143 | ochoa | Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3) | May be involved in the calcium-dependent regulation of rhodopsin phosphorylation. |
P38606 | ATP6V1A | S160 | ochoa | V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha) | Catalytic subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (PubMed:8463241). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (PubMed:32001091). In aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of Fe(2+) prolyl hydroxylase (PHD) enzymes, and leading to HIF1A hydroxylation and subsequent proteasomal degradation (PubMed:28296633). May play a role in neurite development and synaptic connectivity (PubMed:29668857). {ECO:0000250|UniProtKB:P50516, ECO:0000269|PubMed:28296633, ECO:0000269|PubMed:29668857, ECO:0000269|PubMed:8463241, ECO:0000303|PubMed:32001091}.; FUNCTION: (Microbial infection) Plays an important role in virion uncoating during Rabies virus replication after membrane fusion. Specifically, participates in the dissociation of incoming viral matrix M proteins uncoating through direct interaction. {ECO:0000269|PubMed:33208464}. |
P46060 | RANGAP1 | S504 | psp | Ran GTPase-activating protein 1 (RanGAP1) | GTPase activator for RAN (PubMed:16428860, PubMed:8146159, PubMed:8896452). Converts cytoplasmic GTP-bound RAN to GDP-bound RAN, which is essential for RAN-mediated nuclear import and export (PubMed:27160050, PubMed:8896452). Mediates dissociation of cargo from nuclear export complexes containing XPO1, RAN and RANBP2 after nuclear export (PubMed:27160050). {ECO:0000269|PubMed:16428860, ECO:0000269|PubMed:27160050, ECO:0000269|PubMed:8146159, ECO:0000269|PubMed:8896452}. |
P46937 | YAP1 | S436 | psp | Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) | Transcriptional regulator with dual roles as a coactivator and corepressor. Critical downstream regulatory target in the Hippo signaling pathway, crucial for organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:17974916, PubMed:18280240, PubMed:18579750, PubMed:21364637, PubMed:30447097). The Hippo signaling pathway core involves a kinase cascade featuring STK3/MST2 and STK4/MST1, along with its regulatory partner SAV1, which phosphorylates and activates LATS1/2 in complex with their regulatory protein, MOB1. This activation leads to the phosphorylation and inactivation of the YAP1 oncoprotein and WWTR1/TAZ (PubMed:18158288). Phosphorylation of YAP1 by LATS1/2 prevents its nuclear translocation, thereby regulating the expression of its target genes (PubMed:18158288, PubMed:26598551, PubMed:34404733). The transcriptional regulation of gene expression requires TEAD transcription factors and modulates cell growth, anchorage-independent growth, and induction of epithelial-mesenchymal transition (EMT) (PubMed:18579750). Plays a key role in tissue tension and 3D tissue shape by regulating the cortical actomyosin network, acting via ARHGAP18, a Rho GTPase activating protein that suppresses F-actin polymerization (PubMed:25778702). It also suppresses ciliogenesis by acting as a transcriptional corepressor of TEAD4 target genes AURKA and PLK1 (PubMed:25849865). In conjunction with WWTR1, regulates TGFB1-dependent SMAD2 and SMAD3 nuclear accumulation (By similarity). Synergizes with WBP2 to enhance PGR activity (PubMed:16772533). {ECO:0000250|UniProtKB:P46938, ECO:0000269|PubMed:16772533, ECO:0000269|PubMed:17974916, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:18280240, ECO:0000269|PubMed:18579750, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:25778702, ECO:0000269|PubMed:25849865, ECO:0000269|PubMed:26598551, ECO:0000269|PubMed:30447097, ECO:0000269|PubMed:34404733}.; FUNCTION: [Isoform 2]: Activates the C-terminal fragment (CTF) of ERBB4 (isoform 3). {ECO:0000269|PubMed:12807903}.; FUNCTION: [Isoform 3]: Activates the C-terminal fragment (CTF) of ERBB4 (isoform 3). {ECO:0000269|PubMed:12807903}. |
P48960 | ADGRE5 | S815 | ochoa | Adhesion G protein-coupled receptor E5 (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: Adhesion G protein-coupled receptor E5 subunit alpha; Adhesion G protein-coupled receptor E5 subunit beta] | Receptor potentially involved in both adhesion and signaling processes early after leukocyte activation. Plays an essential role in leukocyte migration. {ECO:0000250|UniProtKB:Q9Z0M6}. |
P55072 | VCP | S37 | ochoa | Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP) | Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1, VCP and NPLOC4 binds ubiquitinated proteins and is necessary for the export of misfolded proteins from the ER to the cytoplasm, where they are degraded by the proteasome. The NPLOC4-UFD1-VCP complex regulates spindle disassembly at the end of mitosis and is necessary for the formation of a closed nuclear envelope. Regulates E3 ubiquitin-protein ligase activity of RNF19A. Component of the VCP/p97-AMFR/gp78 complex that participates in the final step of the sterol-mediated ubiquitination and endoplasmic reticulum-associated degradation (ERAD) of HMGCR. Mediates the endoplasmic reticulum-associated degradation of CHRNA3 in cortical neurons as part of the STUB1-VCP-UBXN2A complex (PubMed:26265139). Involved in endoplasmic reticulum stress-induced pre-emptive quality control, a mechanism that selectively attenuates the translocation of newly synthesized proteins into the endoplasmic reticulum and reroutes them to the cytosol for proteasomal degradation (PubMed:26565908). Involved in clearance process by mediating G3BP1 extraction from stress granules (PubMed:29804830, PubMed:34739333). Also involved in DNA damage response: recruited to double-strand breaks (DSBs) sites in a RNF8- and RNF168-dependent manner and promotes the recruitment of TP53BP1 at DNA damage sites (PubMed:22020440, PubMed:22120668). Recruited to stalled replication forks by SPRTN: may act by mediating extraction of DNA polymerase eta (POLH) to prevent excessive translesion DNA synthesis and limit the incidence of mutations induced by DNA damage (PubMed:23042605, PubMed:23042607). Together with SPRTN metalloprotease, involved in the repair of covalent DNA-protein cross-links (DPCs) during DNA synthesis (PubMed:32152270). Involved in interstrand cross-link repair in response to replication stress by mediating unloading of the ubiquitinated CMG helicase complex (By similarity). Mediates extraction of PARP1 trapped to chromatin: recognizes and binds ubiquitinated PARP1 and promotes its removal (PubMed:35013556). Required for cytoplasmic retrotranslocation of stressed/damaged mitochondrial outer-membrane proteins and their subsequent proteasomal degradation (PubMed:16186510, PubMed:21118995). Essential for the maturation of ubiquitin-containing autophagosomes and the clearance of ubiquitinated protein by autophagy (PubMed:20104022, PubMed:27753622). Acts as a negative regulator of type I interferon production by interacting with RIGI: interaction takes place when RIGI is ubiquitinated via 'Lys-63'-linked ubiquitin on its CARD domains, leading to recruit RNF125 and promote ubiquitination and degradation of RIGI (PubMed:26471729). May play a role in the ubiquitin-dependent sorting of membrane proteins to lysosomes where they undergo degradation (PubMed:21822278). May more particularly play a role in caveolins sorting in cells (PubMed:21822278, PubMed:23335559). By controlling the steady-state expression of the IGF1R receptor, indirectly regulates the insulin-like growth factor receptor signaling pathway (PubMed:26692333). {ECO:0000250|UniProtKB:P23787, ECO:0000269|PubMed:15456787, ECO:0000269|PubMed:16168377, ECO:0000269|PubMed:16186510, ECO:0000269|PubMed:20104022, ECO:0000269|PubMed:21118995, ECO:0000269|PubMed:21822278, ECO:0000269|PubMed:22020440, ECO:0000269|PubMed:22120668, ECO:0000269|PubMed:22607976, ECO:0000269|PubMed:23042605, ECO:0000269|PubMed:23042607, ECO:0000269|PubMed:23335559, ECO:0000269|PubMed:26265139, ECO:0000269|PubMed:26471729, ECO:0000269|PubMed:26565908, ECO:0000269|PubMed:26692333, ECO:0000269|PubMed:27753622, ECO:0000269|PubMed:29804830, ECO:0000269|PubMed:32152270, ECO:0000269|PubMed:34739333, ECO:0000269|PubMed:35013556}. |
P60709 | ACTB | Y166 | ochoa | Actin, cytoplasmic 1 (EC 3.6.4.-) (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed] | Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed:25255767, PubMed:29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed:29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged DNA (PubMed:29925947). Plays a role in the assembly of the gamma-tubulin ring complex (gTuRC), which regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments (PubMed:39321809, PubMed:38609661). Part of the ACTR1A/ACTB filament around which the dynactin complex is built (By similarity). The dynactin multiprotein complex activates the molecular motor dynein for ultra-processive transport along microtubules (By similarity). {ECO:0000250|UniProtKB:Q6QAQ1, ECO:0000269|PubMed:25255767, ECO:0000269|PubMed:29581253, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:38609661, ECO:0000269|PubMed:39321809}. |
P61266 | STX1B | S58 | ochoa | Syntaxin-1B (Syntaxin-1B1) (Syntaxin-1B2) | Potentially involved in docking of synaptic vesicles at presynaptic active zones. May mediate Ca(2+)-regulation of exocytosis acrosomal reaction in sperm (By similarity). {ECO:0000250}. |
P61601 | NCALD | S143 | ochoa | Neurocalcin-delta | May be involved in the calcium-dependent regulation of rhodopsin phosphorylation. Binds three calcium ions. |
P62736 | ACTA2 | Y168 | ochoa | Actin, aortic smooth muscle (EC 3.6.4.-) (Alpha-actin-2) (Cell growth-inhibiting gene 46 protein) [Cleaved into: Actin, aortic smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P63261 | ACTG1 | Y166 | ochoa | Actin, cytoplasmic 2 (EC 3.6.4.-) (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. May play a role in the repair of noise-induced stereocilia gaps thereby maintains hearing sensitivity following loud noise damage (By similarity). {ECO:0000250|UniProtKB:P63260, ECO:0000305|PubMed:29581253}. |
P63267 | ACTG2 | Y167 | ochoa | Actin, gamma-enteric smooth muscle (EC 3.6.4.-) (Alpha-actin-3) (Gamma-2-actin) (Smooth muscle gamma-actin) [Cleaved into: Actin, gamma-enteric smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68032 | ACTC1 | Y168 | ochoa | Actin, alpha cardiac muscle 1 (EC 3.6.4.-) (Alpha-cardiac actin) [Cleaved into: Actin, alpha cardiac muscle 1, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68104 | EEF1A1 | S291 | ochoa | Elongation factor 1-alpha 1 (EF-1-alpha-1) (EC 3.6.5.-) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7) | Translation elongation factor that catalyzes the GTP-dependent binding of aminoacyl-tRNA (aa-tRNA) to the A-site of ribosomes during the elongation phase of protein synthesis (PubMed:26593721, PubMed:26651998, PubMed:36123449, PubMed:36264623, PubMed:36638793). Base pairing between the mRNA codon and the aa-tRNA anticodon promotes GTP hydrolysis, releasing the aa-tRNA from EEF1A1 and allowing its accommodation into the ribosome (PubMed:26593721, PubMed:26651998, PubMed:36123449, PubMed:36264623, PubMed:36638793). The growing protein chain is subsequently transferred from the P-site peptidyl tRNA to the A-site aa-tRNA, extending it by one amino acid through ribosome-catalyzed peptide bond formation (PubMed:26593721, PubMed:26651998, PubMed:36123449, PubMed:36264623). Also plays a role in the positive regulation of IFNG transcription in T-helper 1 cells as part of an IFNG promoter-binding complex with TXK and PARP1 (PubMed:17177976). Also plays a role in cytoskeleton organization by promoting actin bundling (By similarity). {ECO:0000250|UniProtKB:P68105, ECO:0000269|PubMed:17177976, ECO:0000269|PubMed:26593721, ECO:0000269|PubMed:26651998, ECO:0000269|PubMed:36123449, ECO:0000269|PubMed:36264623, ECO:0000269|PubMed:36638793}.; FUNCTION: (Microbial infection) Required for the translation of viral proteins and viral replication during human coronavirus SARS-CoV-2 infection. {ECO:0000269|PubMed:33495306}. |
P68133 | ACTA1 | Y168 | ochoa | Actin, alpha skeletal muscle (EC 3.6.4.-) (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P84074 | HPCA | S143 | ochoa | Neuron-specific calcium-binding protein hippocalcin (Calcium-binding protein BDR-2) | Calcium-binding protein that may play a role in the regulation of voltage-dependent calcium channels (PubMed:28398555). May also play a role in cyclic-nucleotide-mediated signaling through the regulation of adenylate and guanylate cyclases (By similarity). {ECO:0000250|UniProtKB:P84076, ECO:0000269|PubMed:28398555}. |
Q05639 | EEF1A2 | S291 | ochoa | Elongation factor 1-alpha 2 (EF-1-alpha-2) (EC 3.6.5.-) (Eukaryotic elongation factor 1 A-2) (eEF1A-2) (Statin-S1) | Translation elongation factor that catalyzes the GTP-dependent binding of aminoacyl-tRNA (aa-tRNA) to the A-site of ribosomes during the elongation phase of protein synthesis. Base pairing between the mRNA codon and the aa-tRNA anticodon promotes GTP hydrolysis, releasing the aa-tRNA from EEF1A1 and allowing its accommodation into the ribosome (By similarity). The growing protein chain is subsequently transferred from the P-site peptidyl tRNA to the A-site aa-tRNA, extending it by one amino acid through ribosome-catalyzed peptide bond formation (By similarity). {ECO:0000250|UniProtKB:P68104, ECO:0000250|UniProtKB:Q71V39}. |
Q08881 | ITK | S565 | ochoa | Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) | Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of ITK to the cell membrane, in the vicinity of the stimulated TCR receptor, where it is phosphorylated by LCK. Phosphorylation leads to ITK autophosphorylation and full activation. Once activated, phosphorylates PLCG1, leading to the activation of this lipase and subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. Phosphorylates 2 essential adapter proteins: the linker for activation of T-cells/LAT protein and LCP2. Then, a large number of signaling molecules such as VAV1 are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation (PubMed:12186560, PubMed:12682224, PubMed:21725281). Required for TCR-mediated calcium response in gamma-delta T-cells, may also be involved in the modulation of the transcriptomic signature in the Vgamma2-positive subset of immature gamma-delta T-cells (By similarity). Phosphorylates TBX21 at 'Tyr-530' and mediates its interaction with GATA3 (By similarity). {ECO:0000250|UniProtKB:Q03526, ECO:0000269|PubMed:12186560, ECO:0000269|PubMed:12682224, ECO:0000269|PubMed:21725281}. |
Q08AD1 | CAMSAP2 | S900 | ochoa | Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1) | Key microtubule-organizing protein that specifically binds the minus-end of non-centrosomal microtubules and regulates their dynamics and organization (PubMed:23169647, PubMed:24486153, PubMed:24706919). Specifically recognizes growing microtubule minus-ends and autonomously decorates and stabilizes microtubule lattice formed by microtubule minus-end polymerization (PubMed:24486153, PubMed:24706919). Acts on free microtubule minus-ends that are not capped by microtubule-nucleating proteins or other factors and protects microtubule minus-ends from depolymerization (PubMed:24486153, PubMed:24706919). In addition, it also reduces the velocity of microtubule polymerization (PubMed:24486153, PubMed:24706919). Through the microtubule cytoskeleton, also regulates the organization of cellular organelles including the Golgi and the early endosomes (PubMed:27666745). Essential for the tethering, but not for nucleation of non-centrosomal microtubules at the Golgi: together with Golgi-associated proteins AKAP9 and PDE4DIP, required to tether non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement (PubMed:27666745). Also acts as a regulator of neuronal polarity and development: localizes to non-centrosomal microtubule minus-ends in neurons and stabilizes non-centrosomal microtubules, which is required for neuronal polarity, axon specification and dendritic branch formation (PubMed:24908486). Through the microtubule cytoskeleton, regulates the autophagosome transport (PubMed:28726242). {ECO:0000269|PubMed:23169647, ECO:0000269|PubMed:24486153, ECO:0000269|PubMed:24706919, ECO:0000269|PubMed:24908486, ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28726242}. |
Q12873 | CHD3 | S1251 | ochoa | Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.-) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH) | ATP-dependent chromatin-remodeling factor that binds and distorts nucleosomal DNA (PubMed:28977666). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:16428440, PubMed:28977666, PubMed:30397230, PubMed:9804427). Involved in transcriptional repression as part of the NuRD complex (PubMed:27068747). Required for anchoring centrosomal pericentrin in both interphase and mitosis, for spindle organization and centrosome integrity (PubMed:17626165). {ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:17626165, ECO:0000269|PubMed:27068747, ECO:0000269|PubMed:28977666, ECO:0000269|PubMed:30397230, ECO:0000269|PubMed:9804427}. |
Q13416 | ORC2 | S219 | ochoa | Origin recognition complex subunit 2 | Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Binds histone H3 and H4 trimethylation marks H3K9me3, H3K20me3 and H4K27me3. Stabilizes LRWD1, by protecting it from ubiquitin-mediated proteasomal degradation. Also stabilizes ORC3. {ECO:0000269|PubMed:22427655, ECO:0000269|PubMed:22935713}. |
Q14839 | CHD4 | S1245 | ochoa | Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.-) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) | ATP-dependent chromatin-remodeling factor that binds and distorts nucleosomal DNA (PubMed:28977666, PubMed:32543371). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:16428440, PubMed:17626165, PubMed:28977666, PubMed:9804427). Localizes to acetylated damaged chromatin in a ZMYND8-dependent manner, to promote transcriptional repression and double-strand break repair by homologous recombination (PubMed:25593309). Involved in neurogenesis (By similarity). {ECO:0000250|UniProtKB:Q6PDQ2, ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:17626165, ECO:0000269|PubMed:25593309, ECO:0000269|PubMed:28977666, ECO:0000269|PubMed:32543371, ECO:0000269|PubMed:9804427}. |
Q15111 | PLCL1 | S569 | ochoa | Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP) | Involved in an inositol phospholipid-based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol. Component in the phospho-dependent endocytosis process of GABA A receptor (By similarity). Regulates the turnover of receptors and thus contributes to the maintenance of GABA-mediated synaptic inhibition. Its aberrant expression could contribute to the genesis and progression of lung carcinoma. Acts as an inhibitor of PPP1C. {ECO:0000250, ECO:0000269|PubMed:17254016}. |
Q15208 | STK38 | S264 | ochoa | Serine/threonine-protein kinase 38 (EC 2.7.11.1) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1) | Serine/threonine-protein kinase that acts as a negative regulator of MAP3K1/2 signaling (PubMed:12493777, PubMed:15197186, PubMed:17906693, PubMed:7761441). Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2 (PubMed:12493777, PubMed:15197186, PubMed:17906693, PubMed:7761441). Acts as an ufmylation 'reader' in a kinase-independent manner: specifically recognizes and binds mono-ufmylated histone H4 in response to DNA damage, promoting the recruitment of SUV39H1 to the double-strand breaks, resulting in ATM activation (PubMed:32537488). {ECO:0000269|PubMed:12493777, ECO:0000269|PubMed:15197186, ECO:0000269|PubMed:17906693, ECO:0000269|PubMed:32537488, ECO:0000269|PubMed:7761441}. |
Q15293 | RCN1 | S159 | ochoa | Reticulocalbin-1 | May regulate calcium-dependent activities in the endoplasmic reticulum lumen or post-ER compartment. |
Q6ZRV2 | FAM83H | S759 | ochoa | Protein FAM83H | May play a major role in the structural organization and calcification of developing enamel (PubMed:18252228). May play a role in keratin cytoskeleton disassembly by recruiting CSNK1A1 to keratin filaments. Thereby, it may regulate epithelial cell migration (PubMed:23902688). {ECO:0000269|PubMed:18252228, ECO:0000269|PubMed:23902688}. |
Q71RC2 | LARP4 | S660 | ochoa | La-related protein 4 (La ribonucleoprotein domain family member 4) | RNA binding protein that binds to the poly-A tract of mRNA molecules (PubMed:21098120). Associates with the 40S ribosomal subunit and with polysomes (PubMed:21098120). Plays a role in the regulation of mRNA translation (PubMed:21098120). Plays a role in the regulation of cell morphology and cytoskeletal organization (PubMed:21834987, PubMed:27615744). {ECO:0000269|PubMed:21098120, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:27615744}. |
Q7KZI7 | MARK2 | S43 | ochoa | Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) | Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. {ECO:0000269|PubMed:11433294, ECO:0000269|PubMed:12429843, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15158914, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:15365179, ECO:0000269|PubMed:16775013, ECO:0000269|PubMed:16980613, ECO:0000269|PubMed:18626018, ECO:0000269|PubMed:20194617, ECO:0000269|PubMed:23666762}. |
Q7L7V1 | DHX32 | S561 | ochoa | Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 (EC 3.6.4.13) (DEAD/H box 32) (DEAD/H helicase-like protein 1) (DHLP1) (DEAH box protein 32) (HuDDX32) | None |
Q86UP2 | KTN1 | S1180 | ochoa | Kinectin (CG-1 antigen) (Kinesin receptor) | Receptor for kinesin thus involved in kinesin-driven vesicle motility. Accumulates in integrin-based adhesion complexes (IAC) upon integrin aggregation by fibronectin. |
Q86V21 | AACS | S84 | ochoa | Acetoacetyl-CoA synthetase (EC 6.2.1.16) (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog) | Converts acetoacetate to acetoacetyl-CoA in the cytosol (By similarity). Ketone body-utilizing enzyme, responsible for the synthesis of cholesterol and fatty acids (By similarity). {ECO:0000250|UniProtKB:Q9D2R0, ECO:0000250|UniProtKB:Q9JMI1}. |
Q8IXW5 | RPAP2 | S426 | ochoa | Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 (EC 3.1.3.16) (RNA polymerase II-associated protein 2) | Protein phosphatase that displays CTD phosphatase activity and regulates transcription of snRNA genes. Recognizes and binds phosphorylated 'Ser-7' of the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit POLR2A, and mediates dephosphorylation of 'Ser-5' of the CTD, thereby promoting transcription of snRNA genes (PubMed:17643375, PubMed:22137580, PubMed:24997600). Downstream of EIF2AK3/PERK, dephosphorylates ERN1, a sensor for the endoplasmic reticulum unfolded protein response (UPR), to abort failed ER-stress adaptation and trigger apoptosis (PubMed:30118681). {ECO:0000269|PubMed:17643375, ECO:0000269|PubMed:22137580, ECO:0000269|PubMed:24997600, ECO:0000269|PubMed:30118681}. |
Q8IZ21 | PHACTR4 | S533 | ochoa | Phosphatase and actin regulator 4 | Regulator of protein phosphatase 1 (PP1) required for neural tube and optic fissure closure, and enteric neural crest cell (ENCCs) migration during development. Acts as an activator of PP1 by interacting with PPP1CA and preventing phosphorylation of PPP1CA at 'Thr-320'. During neural tube closure, localizes to the ventral neural tube and activates PP1, leading to down-regulate cell proliferation within cranial neural tissue and the neural retina. Also acts as a regulator of migration of enteric neural crest cells (ENCCs) by activating PP1, leading to dephosphorylation and subsequent activation of cofilin (COF1 or COF2) and repression of the integrin signaling through the RHO/ROCK pathway (By similarity). {ECO:0000250}. |
Q8NG31 | KNL1 | S1022 | ochoa | Outer kinetochore KNL1 complex subunit KNL1 (ALL1-fused gene from chromosome 15q14 protein) (AF15q14) (Bub-linking kinetochore protein) (Blinkin) (Cancer susceptibility candidate gene 5 protein) (Cancer/testis antigen 29) (CT29) (Kinetochore scaffold 1) (Kinetochore-null protein 1) (Protein CASC5) (Protein D40/AF15q14) | Acts as a component of the outer kinetochore KNL1 complex that serves as a docking point for spindle assembly checkpoint components and mediates microtubule-kinetochore interactions (PubMed:15502821, PubMed:17981135, PubMed:18045986, PubMed:19893618, PubMed:21199919, PubMed:22000412, PubMed:22331848, PubMed:27881301, PubMed:30100357). Kinetochores, consisting of a centromere-associated inner segment and a microtubule-contacting outer segment, play a crucial role in chromosome segregation by mediating the physical connection between centromeric DNA and spindle microtubules (PubMed:18045986, PubMed:19893618, PubMed:27881301). The outer kinetochore is made up of the ten-subunit KMN network, comprising the MIS12, NDC80 and KNL1 complexes, and auxiliary microtubule-associated components; together they connect the outer kinetochore with the inner kinetochore, bind microtubules, and mediate interactions with mitotic checkpoint proteins that delay anaphase until chromosomes are bioriented on the spindle (PubMed:17981135, PubMed:19893618, PubMed:22000412, PubMed:38459127, PubMed:38459128). Required for kinetochore binding by a distinct subset of kMAPs (kinetochore-bound microtubule-associated proteins) and motors (PubMed:19893618). Acts in coordination with CENPK to recruit the NDC80 complex to the outer kinetochore (PubMed:18045986, PubMed:27881301). Can bind either to microtubules or to the protein phosphatase 1 (PP1) catalytic subunits PPP1CA and PPP1CC (via overlapping binding sites), it has higher affinity for PP1 (PubMed:30100357). Recruits MAD2L1 to the kinetochore and also directly links BUB1 and BUB1B to the kinetochore (PubMed:17981135, PubMed:19893618, PubMed:22000412, PubMed:22331848, PubMed:25308863). In addition to orienting mitotic chromosomes, it is also essential for alignment of homologous chromosomes during meiotic metaphase I (By similarity). In meiosis I, required to activate the spindle assembly checkpoint at unattached kinetochores to correct erroneous kinetochore-microtubule attachments (By similarity). {ECO:0000250|UniProtKB:Q66JQ7, ECO:0000269|PubMed:15502821, ECO:0000269|PubMed:17981135, ECO:0000269|PubMed:18045986, ECO:0000269|PubMed:19893618, ECO:0000269|PubMed:21199919, ECO:0000269|PubMed:22000412, ECO:0000269|PubMed:22331848, ECO:0000269|PubMed:25308863, ECO:0000269|PubMed:27881301, ECO:0000269|PubMed:30100357, ECO:0000269|PubMed:38459127, ECO:0000269|PubMed:38459128}. |
Q8NHV4 | NEDD1 | S637 | psp | Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1) | Required for mitosis progression. Promotes the nucleation of microtubules from the spindle. {ECO:0000269|PubMed:19029337, ECO:0000269|PubMed:19509060}. |
Q8TAA9 | VANGL1 | S83 | ochoa | Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1) | None |
Q8WVK2 | SNRNP27 | S132 | ochoa | U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein (U4/U6.U5 snRNP 27 kDa protein) (U4/U6.U5-27K) (Nucleic acid-binding protein RY-1) (U4/U6.U5 tri-snRNP-associated 27 kDa protein) (27K) (U4/U6.U5 tri-snRNP-associated protein 3) | May play a role in mRNA splicing. |
Q92851 | CASP10 | S266 | ochoa | Caspase-10 (CASP-10) (EC 3.4.22.63) (Apoptotic protease Mch-4) (FAS-associated death domain protein interleukin-1B-converting enzyme 2) (FLICE2) (ICE-like apoptotic protease 4) [Cleaved into: Caspase-10 subunit p23/17; Caspase-10 subunit p12] | Involved in the activation cascade of caspases responsible for apoptosis execution. Recruited to both Fas- and TNFR-1 receptors in a FADD dependent manner. May participate in the granzyme B apoptotic pathways. Cleaves and activates effector caspases CASP3, CASP4, CASP6, CASP7, CASP8 and CASP9. Hydrolyzes the small- molecule substrates, Tyr-Val-Ala-Asp-|-AMC and Asp-Glu-Val-Asp-|-AMC. {ECO:0000269|PubMed:11717445, ECO:0000269|PubMed:16916640}.; FUNCTION: Isoform 7 can enhance NF-kappaB activity but promotes only slight apoptosis. {ECO:0000269|PubMed:17822854}.; FUNCTION: Isoform C is proteolytically inactive. {ECO:0000269|PubMed:11717445}. |
Q96J84 | KIRREL1 | S737 | ochoa | Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1) | Required for proper function of the glomerular filtration barrier. It is involved in the maintenance of a stable podocyte architecture with interdigitating foot processes connected by specialized cell-cell junctions, known as the slit diaphragm (PubMed:31472902). It is a signaling protein that needs the presence of TEC kinases to fully trans-activate the transcription factor AP-1 (By similarity). {ECO:0000250, ECO:0000269|PubMed:31472902}. |
Q96RL1 | UIMC1 | S350 | ochoa | BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Retinoid X receptor-interacting protein 110) (Ubiquitin interaction motif-containing protein 1) | Ubiquitin-binding protein (PubMed:24627472). Specifically recognizes and binds 'Lys-63'-linked ubiquitin (PubMed:19328070, Ref.38). Plays a central role in the BRCA1-A complex by specifically binding 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. Also weakly binds monoubiquitin but with much less affinity than 'Lys-63'-linked ubiquitin. May interact with monoubiquitinated histones H2A and H2B; the relevance of such results is however unclear in vivo. Does not bind Lys-48'-linked ubiquitin. May indirectly act as a transcriptional repressor by inhibiting the interaction of NR6A1 with the corepressor NCOR1. {ECO:0000269|PubMed:12080054, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:17525341, ECO:0000269|PubMed:17525342, ECO:0000269|PubMed:17621610, ECO:0000269|PubMed:17643121, ECO:0000269|PubMed:19015238, ECO:0000269|PubMed:19202061, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19328070, ECO:0000269|PubMed:24627472, ECO:0000269|Ref.38}. |
Q96T58 | SPEN | S1392 | ochoa | Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) | May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the association between NOTCH1 and RBPSUH, and therefore suppresses the transactivation activity of Notch signaling. Blocks the differentiation of precursor B-cells into marginal zone B-cells. Probably represses transcription via the recruitment of large complexes containing histone deacetylase proteins. May bind both to DNA and RNA. {ECO:0000250|UniProtKB:Q62504, ECO:0000269|PubMed:11331609, ECO:0000269|PubMed:12374742}. |
Q99615 | DNAJC7 | S393 | ochoa | DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2) | Acts as a co-chaperone regulating the molecular chaperones HSP70 and HSP90 in folding of steroid receptors, such as the glucocorticoid receptor and the progesterone receptor. Proposed to act as a recycling chaperone by facilitating the return of chaperone substrates to early stages of chaperoning if further folding is required. In vitro, induces ATP-independent dissociation of HSP90 but not of HSP70 from the chaperone-substrate complexes. Recruits NR1I3 to the cytoplasm (By similarity). {ECO:0000250, ECO:0000269|PubMed:12853476, ECO:0000269|PubMed:18620420}. |
Q9GZZ9 | UBA5 | S44 | ochoa | Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1) | E1-like enzyme which specifically catalyzes the first step in ufmylation (PubMed:15071506, PubMed:18442052, PubMed:20368332, PubMed:25219498, PubMed:26929408, PubMed:27545674, PubMed:27545681, PubMed:27653677, PubMed:30412706, PubMed:30626644, PubMed:34588452). Activates UFM1 by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a UFM1-E1 thioester and free AMP (PubMed:20368332, PubMed:26929408, PubMed:27653677, PubMed:30412706). Activates UFM1 via a trans-binding mechanism, in which UFM1 interacts with distinct sites in both subunits of the UBA5 homodimer (PubMed:27653677). Trans-binding also promotes stabilization of the UBA5 homodimer, and enhances ATP-binding (PubMed:29295865). Transfer of UFM1 from UBA5 to the E2-like enzyme UFC1 also takes place using a trans mechanism (PubMed:27653677, PubMed:34588452). Ufmylation plays a key role in various processes, such as ribosome recycling, response to DNA damage, interferon response or reticulophagy (also called ER-phagy) (PubMed:30412706, PubMed:32160526, PubMed:35394863). Ufmylation is essential for erythroid differentiation of both megakaryocytes and erythrocytes (By similarity). {ECO:0000250|UniProtKB:Q8VE47, ECO:0000269|PubMed:15071506, ECO:0000269|PubMed:18442052, ECO:0000269|PubMed:20368332, ECO:0000269|PubMed:25219498, ECO:0000269|PubMed:26929408, ECO:0000269|PubMed:27545674, ECO:0000269|PubMed:27545681, ECO:0000269|PubMed:27653677, ECO:0000269|PubMed:29295865, ECO:0000269|PubMed:30412706, ECO:0000269|PubMed:30626644, ECO:0000269|PubMed:32160526, ECO:0000269|PubMed:34588452, ECO:0000269|PubMed:35394863}. |
Q9H4B6 | SAV1 | S36 | psp | Protein salvador homolog 1 (45 kDa WW domain protein) (hWW45) | Regulator of STK3/MST2 and STK4/MST1 in the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:29063833). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. SAV1 is required for STK3/MST2 and STK4/MST1 activation and promotes cell-cycle exit and terminal differentiation in developing epithelial tissues. Plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with STK3/MST2, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. {ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:19212654, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:29063833}. |
Q9H814 | PHAX | S226 | ochoa | Phosphorylated adapter RNA export protein (RNA U small nuclear RNA export adapter protein) | A phosphoprotein adapter involved in the XPO1-mediated U snRNA export from the nucleus (PubMed:39011894). Bridge components required for U snRNA export, the cap binding complex (CBC)-bound snRNA on the one hand and the GTPase Ran in its active GTP-bound form together with the export receptor XPO1 on the other. Its phosphorylation in the nucleus is required for U snRNA export complex assembly and export, while its dephosphorylation in the cytoplasm causes export complex disassembly. It is recycled back to the nucleus via the importin alpha/beta heterodimeric import receptor. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Its compartmentalized phosphorylation cycle may also contribute to the directionality of export. Binds strongly to m7G-capped U1 and U5 small nuclear RNAs (snRNAs) in a sequence-unspecific manner and phosphorylation-independent manner (By similarity). Also plays a role in the biogenesis of U3 small nucleolar RNA (snoRNA). Involved in the U3 snoRNA transport from nucleoplasm to Cajal bodies. Binds strongly to m7G-capped U3, U8 and U13 precursor snoRNAs and weakly to trimethylated (TMG)-capped U3, U8 and U13 snoRNAs. Also binds to telomerase RNA. {ECO:0000250, ECO:0000269|PubMed:15574332, ECO:0000269|PubMed:15574333}. |
Q9NYP3 | DONSON | S542 | ochoa | Protein downstream neighbor of Son (B17) | Replisome component that maintains genome stability by protecting stalled or damaged replication forks. After the induction of replication stress, required for the stabilization of stalled replication forks, the efficient activation of the intra-S-phase and G/2M cell-cycle checkpoints and the maintenance of genome stability. {ECO:0000269|PubMed:28191891}. |
Q9ULK5 | VANGL2 | S79 | ochoa | Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2) | Involved in the control of early morphogenesis and patterning of both axial midline structures and the development of neural plate. Plays a role in the regulation of planar cell polarity, particularly in the orientation of stereociliary bundles in the cochlea. Required for polarization and movement of myocardializing cells in the outflow tract and seems to act via RHOA signaling to regulate this process. Required for cell surface localization of FZD3 and FZD6 in the inner ear (By similarity). {ECO:0000250|UniProtKB:Q91ZD4}. |
Q9Y2H1 | STK38L | S265 | ochoa | Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2) | Involved in the regulation of structural processes in differentiating and mature neuronal cells. {ECO:0000250, ECO:0000269|PubMed:15037617, ECO:0000269|PubMed:15067004}. |
Q9Y520 | PRRC2C | S1500 | ochoa | Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C) | Required for efficient formation of stress granules. {ECO:0000269|PubMed:29395067}. |
P63104 | YWHAZ | S156 | Sugiyama | 14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1) | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways (PubMed:14578935, PubMed:15071501, PubMed:15644438, PubMed:16376338, PubMed:16959763, PubMed:31024343, PubMed:9360956). Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif (PubMed:35662396). Binding generally results in the modulation of the activity of the binding partner (PubMed:35662396). Promotes cytosolic retention and inactivation of TFEB transcription factor by binding to phosphorylated TFEB (PubMed:35662396). Induces ARHGEF7 activity on RAC1 as well as lamellipodia and membrane ruffle formation (PubMed:16959763). In neurons, regulates spine maturation through the modulation of ARHGEF7 activity (By similarity). {ECO:0000250|UniProtKB:O55043, ECO:0000269|PubMed:14578935, ECO:0000269|PubMed:15071501, ECO:0000269|PubMed:15644438, ECO:0000269|PubMed:16376338, ECO:0000269|PubMed:16959763, ECO:0000269|PubMed:31024343, ECO:0000269|PubMed:35662396, ECO:0000269|PubMed:9360956}. |
O14910 | LIN7A | S135 | Sugiyama | Protein lin-7 homolog A (Lin-7A) (hLin-7) (Mammalian lin-seven protein 1) (MALS-1) (Tax interaction protein 33) (TIP-33) (Vertebrate lin-7 homolog 1) (Veli-1) | Plays a role in establishing and maintaining the asymmetric distribution of channels and receptors at the plasma membrane of polarized cells. Forms membrane-associated multiprotein complexes that may regulate delivery and recycling of proteins to the correct membrane domains. The tripartite complex composed of LIN7 (LIN7A, LIN7B or LIN7C), CASK and APBA1 associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules (By similarity). This complex may have the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Ensures the proper localization of GRIN2B (subunit 2B of the NMDA receptor) to neuronal postsynaptic density and may function in localizing synaptic vesicles at synapses where it is recruited by beta-catenin and cadherin. Required to localize Kir2 channels, GABA transporter (SLC6A12) and EGFR/ERBB1, ERBB2, ERBB3 and ERBB4 to the basolateral membrane of epithelial cells. {ECO:0000250|UniProtKB:Q8JZS0, ECO:0000269|PubMed:12967566}. |
P14868 | DARS1 | S32 | Sugiyama | Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein) | Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000250|UniProtKB:P15178}. |
Q9HAP6 | LIN7B | S120 | Sugiyama | Protein lin-7 homolog B (Lin-7B) (hLin7B) (Mammalian lin-seven protein 2) (MALS-2) (Vertebrate lin-7 homolog 2) (Veli-2) (hVeli2) | Plays a role in establishing and maintaining the asymmetric distribution of channels and receptors at the plasma membrane of polarized cells. Forms membrane-associated multiprotein complexes that may regulate delivery and recycling of proteins to the correct membrane domains. The tripartite complex composed of LIN7 (LIN7A, LIN7B or LIN7C), CASK and APBA1 associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules (By similarity). This complex may have the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Ensures the proper localization of GRIN2B (subunit 2B of the NMDA receptor) to neuronal postsynaptic density and may function in localizing synaptic vesicles at synapses where it is recruited by beta-catenin and cadherin. Required to localize Kir2 channels, GABA transporter (SLC6A12) and EGFR/ERBB1, ERBB2, ERBB3 and ERBB4 to the basolateral membrane of epithelial cells. May increase the amplitude of ASIC3 acid-evoked currents by stabilizing the channel at the cell surface (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:O88951, ECO:0000269|PubMed:11742811}. |
Q9NUP9 | LIN7C | S120 | Sugiyama | Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3) | Plays a role in establishing and maintaining the asymmetric distribution of channels and receptors at the plasma membrane of polarized cells. Forms membrane-associated multiprotein complexes that may regulate delivery and recycling of proteins to the correct membrane domains. The tripartite complex composed of LIN7 (LIN7A, LIN7B or LIN7C), CASK and APBA1 associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules (By similarity). This complex may have the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Ensures the proper localization of GRIN2B (subunit 2B of the NMDA receptor) to neuronal postsynaptic density and may function in localizing synaptic vesicles at synapses where it is recruited by beta-catenin and cadherin. Required to localize Kir2 channels, GABA transporter (SLC6A12) and EGFR/ERBB1, ERBB2, ERBB3 and ERBB4 to the basolateral membrane of epithelial cells. {ECO:0000250|UniProtKB:O88952}. |
P49327 | FASN | S2032 | Sugiyama | Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)] | Fatty acid synthetase is a multifunctional enzyme that catalyzes the de novo biosynthesis of long-chain saturated fatty acids starting from acetyl-CoA and malonyl-CoA in the presence of NADPH. This multifunctional protein contains 7 catalytic activities and a site for the binding of the prosthetic group 4'-phosphopantetheine of the acyl carrier protein ([ACP]) domain. {ECO:0000269|PubMed:16215233, ECO:0000269|PubMed:16969344, ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}.; FUNCTION: (Microbial infection) Fatty acid synthetase activity is required for SARS coronavirus-2/SARS-CoV-2 replication. {ECO:0000269|PubMed:34320401}. |
O14910 | LIN7A | S130 | Sugiyama | Protein lin-7 homolog A (Lin-7A) (hLin-7) (Mammalian lin-seven protein 1) (MALS-1) (Tax interaction protein 33) (TIP-33) (Vertebrate lin-7 homolog 1) (Veli-1) | Plays a role in establishing and maintaining the asymmetric distribution of channels and receptors at the plasma membrane of polarized cells. Forms membrane-associated multiprotein complexes that may regulate delivery and recycling of proteins to the correct membrane domains. The tripartite complex composed of LIN7 (LIN7A, LIN7B or LIN7C), CASK and APBA1 associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules (By similarity). This complex may have the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Ensures the proper localization of GRIN2B (subunit 2B of the NMDA receptor) to neuronal postsynaptic density and may function in localizing synaptic vesicles at synapses where it is recruited by beta-catenin and cadherin. Required to localize Kir2 channels, GABA transporter (SLC6A12) and EGFR/ERBB1, ERBB2, ERBB3 and ERBB4 to the basolateral membrane of epithelial cells. {ECO:0000250|UniProtKB:Q8JZS0, ECO:0000269|PubMed:12967566}. |
Q9HAP6 | LIN7B | S115 | Sugiyama | Protein lin-7 homolog B (Lin-7B) (hLin7B) (Mammalian lin-seven protein 2) (MALS-2) (Vertebrate lin-7 homolog 2) (Veli-2) (hVeli2) | Plays a role in establishing and maintaining the asymmetric distribution of channels and receptors at the plasma membrane of polarized cells. Forms membrane-associated multiprotein complexes that may regulate delivery and recycling of proteins to the correct membrane domains. The tripartite complex composed of LIN7 (LIN7A, LIN7B or LIN7C), CASK and APBA1 associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules (By similarity). This complex may have the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Ensures the proper localization of GRIN2B (subunit 2B of the NMDA receptor) to neuronal postsynaptic density and may function in localizing synaptic vesicles at synapses where it is recruited by beta-catenin and cadherin. Required to localize Kir2 channels, GABA transporter (SLC6A12) and EGFR/ERBB1, ERBB2, ERBB3 and ERBB4 to the basolateral membrane of epithelial cells. May increase the amplitude of ASIC3 acid-evoked currents by stabilizing the channel at the cell surface (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:O88951, ECO:0000269|PubMed:11742811}. |
Q9NUP9 | LIN7C | S115 | Sugiyama | Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3) | Plays a role in establishing and maintaining the asymmetric distribution of channels and receptors at the plasma membrane of polarized cells. Forms membrane-associated multiprotein complexes that may regulate delivery and recycling of proteins to the correct membrane domains. The tripartite complex composed of LIN7 (LIN7A, LIN7B or LIN7C), CASK and APBA1 associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules (By similarity). This complex may have the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Ensures the proper localization of GRIN2B (subunit 2B of the NMDA receptor) to neuronal postsynaptic density and may function in localizing synaptic vesicles at synapses where it is recruited by beta-catenin and cadherin. Required to localize Kir2 channels, GABA transporter (SLC6A12) and EGFR/ERBB1, ERBB2, ERBB3 and ERBB4 to the basolateral membrane of epithelial cells. {ECO:0000250|UniProtKB:O88952}. |
P27348 | YWHAQ | S156 | Sugiyama | 14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1) | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negatively regulates the kinase activity of PDPK1. {ECO:0000269|PubMed:12177059}. |
Q9Y281 | CFL2 | S70 | Sugiyama | Cofilin-2 (Cofilin, muscle isoform) | Controls reversibly actin polymerization and depolymerization in a pH-sensitive manner. Its F-actin depolymerization activity is regulated by association with CSPR3 (PubMed:19752190). It has the ability to bind G- and F-actin in a 1:1 ratio of cofilin to actin. It is the major component of intranuclear and cytoplasmic actin rods. Required for muscle maintenance. May play a role during the exchange of alpha-actin forms during the early postnatal remodeling of the sarcomere (By similarity). {ECO:0000250|UniProtKB:P45591, ECO:0000269|PubMed:19752190}. |
P51813 | BMX | S619 | Sugiyama | Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) | Non-receptor tyrosine kinase that plays central but diverse modulatory roles in various signaling processes involved in the regulation of actin reorganization, cell migration, cell proliferation and survival, cell adhesion, and apoptosis. Participates in signal transduction stimulated by growth factor receptors, cytokine receptors, G-protein coupled receptors, antigen receptors and integrins. Induces tyrosine phosphorylation of BCAR1 in response to integrin regulation. Activation of BMX by integrins is mediated by PTK2/FAK1, a key mediator of integrin signaling events leading to the regulation of actin cytoskeleton and cell motility. Plays a critical role in TNF-induced angiogenesis, and implicated in the signaling of TEK and FLT1 receptors, 2 important receptor families essential for angiogenesis. Required for the phosphorylation and activation of STAT3, a transcription factor involved in cell differentiation. Also involved in interleukin-6 (IL6) induced differentiation. Also plays a role in programming adaptive cytoprotection against extracellular stress in different cell systems, salivary epithelial cells, brain endothelial cells, and dermal fibroblasts. May be involved in regulation of endocytosis through its interaction with an endosomal protein RUFY1. May also play a role in the growth and differentiation of hematopoietic cells; as well as in signal transduction in endocardial and arterial endothelial cells. {ECO:0000269|PubMed:10688651, ECO:0000269|PubMed:11331870, ECO:0000269|PubMed:12370298, ECO:0000269|PubMed:12832404, ECO:0000269|PubMed:15788485, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:9520419}. |
P51957 | NEK4 | S766 | Sugiyama | Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2) | Protein kinase that seems to act exclusively upon threonine residues (By similarity). Required for normal entry into proliferative arrest after a limited number of cell divisions, also called replicative senescence. Required for normal cell cycle arrest in response to double-stranded DNA damage. {ECO:0000250|UniProtKB:Q9Z1J2, ECO:0000269|PubMed:22851694}. |
P31946 | YWHAB | S158 | Sugiyama | 14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed] | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negative regulator of osteogenesis. Blocks the nuclear translocation of the phosphorylated form (by AKT1) of SRPK2 and antagonizes its stimulatory effect on cyclin D1 expression resulting in blockage of neuronal apoptosis elicited by SRPK2. Negative regulator of signaling cascades that mediate activation of MAP kinases via AKAP13. {ECO:0000269|PubMed:17717073, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:21224381}. |
Q9BVC4 | MLST8 | S43 | Sugiyama | Target of rapamycin complex subunit LST8 (TORC subunit LST8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (Mammalian lethal with SEC13 protein 8) (mLST8) | Subunit of both mTORC1 and mTORC2, which regulates cell growth and survival in response to nutrient and hormonal signals (PubMed:12718876, PubMed:15268862, PubMed:15467718, PubMed:24403073, PubMed:28489822). mTORC1 is activated in response to growth factors or amino acids (PubMed:12718876, PubMed:15268862, PubMed:15467718, PubMed:24403073). In response to nutrients, mTORC1 is recruited to the lysosome membrane and promotes protein, lipid and nucleotide synthesis by phosphorylating several substrates, such as ribosomal protein S6 kinase (RPS6KB1 and RPS6KB2) and EIF4EBP1 (4E-BP1) (PubMed:12718876, PubMed:15268862, PubMed:15467718, PubMed:24403073). In the same time, it inhibits catabolic pathways by phosphorylating the autophagy initiation components ULK1 and ATG13, as well as transcription factor TFEB, a master regulators of lysosomal biogenesis and autophagy (PubMed:24403073). The mTORC1 complex is inhibited in response to starvation and amino acid depletion (PubMed:24403073). Within mTORC1, MLST8 interacts directly with MTOR and enhances its kinase activity (PubMed:12718876). In nutrient-poor conditions, stabilizes the MTOR-RPTOR interaction and favors RPTOR-mediated inhibition of MTOR activity (PubMed:12718876). As part of the mTORC2 complex, transduces signals from growth factors to pathways involved in proliferation, cytoskeletal organization, lipogenesis and anabolic output (PubMed:15467718, PubMed:35926713). mTORC2 is also activated by growth factors, but seems to be nutrient-insensitive (PubMed:15467718, PubMed:35926713). In response to growth factors, mTORC2 phosphorylates and activates AGC protein kinase family members, including AKT (AKT1, AKT2 and AKT3), PKC (PRKCA, PRKCB and PRKCE) and SGK1 (PubMed:15467718, PubMed:35926713). mTORC2 functions upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors (PubMed:15467718). mTORC2 promotes the serum-induced formation of stress-fibers or F-actin (PubMed:15467718). mTORC2 plays a critical role in AKT1 activation by mediating phosphorylation of different sites depending on the context, such as 'Thr-450', 'Ser-473', 'Ser-477' or 'Thr-479', facilitating the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDPK1/PDK1 which is a prerequisite for full activation (PubMed:15467718). mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422' (PubMed:15467718). mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657' (PubMed:15467718). Within mTORC2, MLST8 acts as a bridge between MAPKAP1/SIN1 and MTOR (PubMed:31085701). {ECO:0000269|PubMed:12718876, ECO:0000269|PubMed:15268862, ECO:0000269|PubMed:15467718, ECO:0000269|PubMed:24403073, ECO:0000269|PubMed:28489822, ECO:0000269|PubMed:31085701, ECO:0000269|PubMed:35926713}. |
P23142 | FBLN1 | S51 | Sugiyama | Fibulin-1 (FIBL-1) | Incorporated into fibronectin-containing matrix fibers. May play a role in cell adhesion and migration along protein fibers within the extracellular matrix (ECM). Could be important for certain developmental processes and contribute to the supramolecular organization of ECM architecture, in particular to those of basement membranes. Has been implicated in a role in cellular transformation and tumor invasion, it appears to be a tumor suppressor. May play a role in haemostasis and thrombosis owing to its ability to bind fibrinogen and incorporate into clots. Could play a significant role in modulating the neurotrophic activities of APP, particularly soluble APP. {ECO:0000269|PubMed:11792823, ECO:0000269|PubMed:9393974, ECO:0000269|PubMed:9466671}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-3371571 | HSF1-dependent transactivation | 1.110223e-16 | 15.955 |
R-HSA-3371568 | Attenuation phase | 1.110223e-16 | 15.955 |
R-HSA-3371556 | Cellular response to heat stress | 1.110223e-16 | 15.955 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 1.110223e-16 | 15.955 |
R-HSA-3371511 | HSF1 activation | 1.110223e-16 | 15.955 |
R-HSA-2262752 | Cellular responses to stress | 4.708916e-08 | 7.327 |
R-HSA-8953897 | Cellular responses to stimuli | 9.754856e-08 | 7.011 |
R-HSA-9913351 | Formation of the dystrophin-glycoprotein complex (DGC) | 1.949084e-07 | 6.710 |
R-HSA-9764561 | Regulation of CDH1 Function | 4.945531e-06 | 5.306 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 1.950705e-05 | 4.710 |
R-HSA-9614399 | Regulation of localization of FOXO transcription factors | 1.152768e-04 | 3.938 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 2.048242e-04 | 3.689 |
R-HSA-75035 | Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 2.034891e-04 | 3.691 |
R-HSA-111447 | Activation of BAD and translocation to mitochondria | 2.814160e-04 | 3.551 |
R-HSA-9755779 | SARS-CoV-2 targets host intracellular signalling and regulatory pathways | 2.814160e-04 | 3.551 |
R-HSA-9735871 | SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 2.814160e-04 | 3.551 |
R-HSA-2028269 | Signaling by Hippo | 4.307259e-04 | 3.366 |
R-HSA-212676 | Dopamine Neurotransmitter Release Cycle | 8.632013e-04 | 3.064 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 1.082677e-03 | 2.966 |
R-HSA-9925563 | Developmental Lineage of Pancreatic Ductal Cells | 1.702362e-03 | 2.769 |
R-HSA-114452 | Activation of BH3-only proteins | 1.766788e-03 | 2.753 |
R-HSA-162582 | Signal Transduction | 1.498579e-03 | 2.824 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 1.691719e-03 | 2.772 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 1.691719e-03 | 2.772 |
R-HSA-69473 | G2/M DNA damage checkpoint | 2.135968e-03 | 2.670 |
R-HSA-196025 | Formation of annular gap junctions | 2.431353e-03 | 2.614 |
R-HSA-69620 | Cell Cycle Checkpoints | 2.386297e-03 | 2.622 |
R-HSA-69481 | G2/M Checkpoints | 2.482677e-03 | 2.605 |
R-HSA-190873 | Gap junction degradation | 2.881268e-03 | 2.540 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 3.106786e-03 | 2.508 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 2.959825e-03 | 2.529 |
R-HSA-9656223 | Signaling by RAF1 mutants | 4.191391e-03 | 2.378 |
R-HSA-5674135 | MAP2K and MAPK activation | 4.191391e-03 | 2.378 |
R-HSA-163765 | ChREBP activates metabolic gene expression | 3.888633e-03 | 2.410 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 4.191391e-03 | 2.378 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 4.367559e-03 | 2.360 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 5.480028e-03 | 2.261 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 5.480028e-03 | 2.261 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 5.480028e-03 | 2.261 |
R-HSA-6802949 | Signaling by RAS mutants | 5.480028e-03 | 2.261 |
R-HSA-437239 | Recycling pathway of L1 | 5.763120e-03 | 2.239 |
R-HSA-9029558 | NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | 5.661418e-03 | 2.247 |
R-HSA-418990 | Adherens junctions interactions | 4.834126e-03 | 2.316 |
R-HSA-1500931 | Cell-Cell communication | 6.630636e-03 | 2.178 |
R-HSA-8876725 | Protein methylation | 7.012348e-03 | 2.154 |
R-HSA-6803207 | TP53 Regulates Transcription of Caspase Activators and Caspases | 7.737170e-03 | 2.111 |
R-HSA-446353 | Cell-extracellular matrix interactions | 7.012348e-03 | 2.154 |
R-HSA-6794361 | Neurexins and neuroligins | 7.309250e-03 | 2.136 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 7.669451e-03 | 2.115 |
R-HSA-1474244 | Extracellular matrix organization | 8.321807e-03 | 2.080 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 8.706616e-03 | 2.060 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 8.706616e-03 | 2.060 |
R-HSA-9613829 | Chaperone Mediated Autophagy | 1.010371e-02 | 1.996 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 1.011005e-02 | 1.995 |
R-HSA-421270 | Cell-cell junction organization | 8.883339e-03 | 2.051 |
R-HSA-9678108 | SARS-CoV-1 Infection | 9.074244e-03 | 2.042 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 1.025029e-02 | 1.989 |
R-HSA-9734767 | Developmental Cell Lineages | 1.082916e-02 | 1.965 |
R-HSA-392517 | Rap1 signalling | 1.095512e-02 | 1.960 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 1.238988e-02 | 1.907 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 1.378732e-02 | 1.861 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 1.378732e-02 | 1.861 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 1.274921e-02 | 1.895 |
R-HSA-446728 | Cell junction organization | 1.366517e-02 | 1.864 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 1.444639e-02 | 1.840 |
R-HSA-166208 | mTORC1-mediated signalling | 1.466217e-02 | 1.834 |
R-HSA-9857377 | Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autopha... | 1.466217e-02 | 1.834 |
R-HSA-70221 | Glycogen breakdown (glycogenolysis) | 1.774724e-02 | 1.751 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 1.527097e-02 | 1.816 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 1.578478e-02 | 1.802 |
R-HSA-9020591 | Interleukin-12 signaling | 1.793683e-02 | 1.746 |
R-HSA-9013694 | Signaling by NOTCH4 | 1.684141e-02 | 1.774 |
R-HSA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activ... | 1.527097e-02 | 1.816 |
R-HSA-397014 | Muscle contraction | 1.832127e-02 | 1.737 |
R-HSA-6807070 | PTEN Regulation | 1.945071e-02 | 1.711 |
R-HSA-9659379 | Sensory processing of sound | 1.965291e-02 | 1.707 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 1.994299e-02 | 1.700 |
R-HSA-9841251 | Mitochondrial unfolded protein response (UPRmt) | 1.994299e-02 | 1.700 |
R-HSA-9833482 | PKR-mediated signaling | 2.024442e-02 | 1.694 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 2.224626e-02 | 1.653 |
R-HSA-6802957 | Oncogenic MAPK signaling | 2.334839e-02 | 1.632 |
R-HSA-447115 | Interleukin-12 family signaling | 2.532794e-02 | 1.596 |
R-HSA-9820448 | Developmental Cell Lineages of the Exocrine Pancreas | 2.562265e-02 | 1.591 |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | 2.716305e-02 | 1.566 |
R-HSA-6794362 | Protein-protein interactions at synapses | 2.334839e-02 | 1.632 |
R-HSA-112310 | Neurotransmitter release cycle | 2.739526e-02 | 1.562 |
R-HSA-9612973 | Autophagy | 2.757921e-02 | 1.559 |
R-HSA-390522 | Striated Muscle Contraction | 2.845469e-02 | 1.546 |
R-HSA-109581 | Apoptosis | 3.067773e-02 | 1.513 |
R-HSA-75157 | FasL/ CD95L signaling | 3.208178e-02 | 1.494 |
R-HSA-8957275 | Post-translational protein phosphorylation | 3.491697e-02 | 1.457 |
R-HSA-9679506 | SARS-CoV Infections | 3.504658e-02 | 1.455 |
R-HSA-9614085 | FOXO-mediated transcription | 3.572213e-02 | 1.447 |
R-HSA-5678895 | Defective CFTR causes cystic fibrosis | 4.732273e-02 | 1.325 |
R-HSA-9646399 | Aggrephagy | 3.815463e-02 | 1.418 |
R-HSA-68689 | CDC6 association with the ORC:origin complex | 5.083930e-02 | 1.294 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 3.815463e-02 | 1.418 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 3.815463e-02 | 1.418 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 3.815463e-02 | 1.418 |
R-HSA-165159 | MTOR signalling | 4.264524e-02 | 1.370 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 4.429566e-02 | 1.354 |
R-HSA-8982491 | Glycogen metabolism | 3.815463e-02 | 1.418 |
R-HSA-5250971 | Toxicity of botulinum toxin type C (botC) | 4.462715e-02 | 1.350 |
R-HSA-190828 | Gap junction trafficking | 4.574335e-02 | 1.340 |
R-HSA-9842860 | Regulation of endogenous retroelements | 3.819489e-02 | 1.418 |
R-HSA-75158 | TRAIL signaling | 5.083930e-02 | 1.294 |
R-HSA-73762 | RNA Polymerase I Transcription Initiation | 4.264524e-02 | 1.370 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 5.054054e-02 | 1.296 |
R-HSA-3928662 | EPHB-mediated forward signaling | 4.574335e-02 | 1.340 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 3.819489e-02 | 1.418 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 5.085201e-02 | 1.294 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 5.280740e-02 | 1.277 |
R-HSA-373760 | L1CAM interactions | 5.379860e-02 | 1.269 |
R-HSA-157858 | Gap junction trafficking and regulation | 5.383497e-02 | 1.269 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 5.643512e-02 | 1.248 |
R-HSA-8951671 | RUNX3 regulates YAP1-mediated transcription | 5.701144e-02 | 1.244 |
R-HSA-113507 | E2F-enabled inhibition of pre-replication complex formation | 5.701144e-02 | 1.244 |
R-HSA-9726840 | SHOC2 M1731 mutant abolishes MRAS complex function | 6.314382e-02 | 1.200 |
R-HSA-9660537 | Signaling by MRAS-complex mutants | 6.923670e-02 | 1.160 |
R-HSA-9726842 | Gain-of-function MRAS complexes activate RAF signaling | 6.923670e-02 | 1.160 |
R-HSA-451308 | Activation of Ca-permeable Kainate Receptor | 8.130496e-02 | 1.090 |
R-HSA-390450 | Folding of actin by CCT/TriC | 8.130496e-02 | 1.090 |
R-HSA-933543 | NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 8.728084e-02 | 1.059 |
R-HSA-9639288 | Amino acids regulate mTORC1 | 6.064382e-02 | 1.217 |
R-HSA-9020933 | Interleukin-23 signaling | 6.923670e-02 | 1.160 |
R-HSA-451306 | Ionotropic activity of kainate receptors | 8.728084e-02 | 1.059 |
R-HSA-430116 | GP1b-IX-V activation signalling | 7.529033e-02 | 1.123 |
R-HSA-9020956 | Interleukin-27 signaling | 8.130496e-02 | 1.090 |
R-HSA-3214815 | HDACs deacetylate histones | 6.415342e-02 | 1.193 |
R-HSA-170984 | ARMS-mediated activation | 7.529033e-02 | 1.123 |
R-HSA-112411 | MAPK1 (ERK2) activation | 7.529033e-02 | 1.123 |
R-HSA-428359 | Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RN... | 8.130496e-02 | 1.090 |
R-HSA-110056 | MAPK3 (ERK1) activation | 8.130496e-02 | 1.090 |
R-HSA-445355 | Smooth Muscle Contraction | 6.064382e-02 | 1.217 |
R-HSA-9013700 | NOTCH4 Activation and Transmission of Signal to the Nucleus | 7.529033e-02 | 1.123 |
R-HSA-5682910 | LGI-ADAM interactions | 8.728084e-02 | 1.059 |
R-HSA-5689877 | Josephin domain DUBs | 8.130496e-02 | 1.090 |
R-HSA-1632852 | Macroautophagy | 8.503803e-02 | 1.070 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 6.164961e-02 | 1.210 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 7.883904e-02 | 1.103 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 6.587898e-02 | 1.181 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 7.967959e-02 | 1.099 |
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 8.266116e-02 | 1.083 |
R-HSA-194138 | Signaling by VEGF | 6.419701e-02 | 1.192 |
R-HSA-5357801 | Programmed Cell Death | 6.027177e-02 | 1.220 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 8.876183e-02 | 1.052 |
R-HSA-157118 | Signaling by NOTCH | 9.090290e-02 | 1.041 |
R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins | 9.245705e-02 | 1.034 |
R-HSA-5683057 | MAPK family signaling cascades | 9.267353e-02 | 1.033 |
R-HSA-6798695 | Neutrophil degranulation | 9.305472e-02 | 1.031 |
R-HSA-418359 | Reduction of cytosolic Ca++ levels | 9.321821e-02 | 1.030 |
R-HSA-168330 | Viral RNP Complexes in the Host Cell Nucleus | 9.321821e-02 | 1.030 |
R-HSA-9694516 | SARS-CoV-2 Infection | 9.429405e-02 | 1.026 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 9.646631e-02 | 1.016 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 1.505276e-01 | 0.822 |
R-HSA-389957 | Prefoldin mediated transfer of substrate to CCT/TriC | 1.724334e-01 | 0.763 |
R-HSA-141424 | Amplification of signal from the kinetochores | 1.257986e-01 | 0.900 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 1.257986e-01 | 0.900 |
R-HSA-373753 | Nephrin family interactions | 1.505276e-01 | 0.822 |
R-HSA-912694 | Regulation of IFNA/IFNB signaling | 1.670100e-01 | 0.777 |
R-HSA-9796292 | Formation of axial mesoderm | 1.049784e-01 | 0.979 |
R-HSA-1059683 | Interleukin-6 signaling | 1.049784e-01 | 0.979 |
R-HSA-6783589 | Interleukin-6 family signaling | 1.778218e-01 | 0.750 |
R-HSA-156842 | Eukaryotic Translation Elongation | 1.434003e-01 | 0.843 |
R-HSA-6788467 | IL-6-type cytokine receptor ligand interactions | 1.049784e-01 | 0.979 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 1.637734e-01 | 0.786 |
R-HSA-2032785 | YAP1- and WWTR1 (TAZ)-stimulated gene expression | 1.108018e-01 | 0.955 |
R-HSA-9705462 | Inactivation of CSF3 (G-CSF) signaling | 1.615513e-01 | 0.792 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 1.279690e-01 | 0.893 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 1.049784e-01 | 0.979 |
R-HSA-9865881 | Complex III assembly | 1.778218e-01 | 0.750 |
R-HSA-170968 | Frs2-mediated activation | 1.049784e-01 | 0.979 |
R-HSA-169893 | Prolonged ERK activation events | 1.223361e-01 | 0.912 |
R-HSA-8854691 | Interleukin-20 family signaling | 1.724334e-01 | 0.763 |
R-HSA-5619084 | ABC transporter disorders | 1.087804e-01 | 0.963 |
R-HSA-450385 | Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 1.165876e-01 | 0.933 |
R-HSA-68877 | Mitotic Prometaphase | 1.612641e-01 | 0.792 |
R-HSA-5673001 | RAF/MAP kinase cascade | 1.438156e-01 | 0.842 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 1.831755e-01 | 0.737 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 1.831755e-01 | 0.737 |
R-HSA-382556 | ABC-family proteins mediated transport | 1.637734e-01 | 0.786 |
R-HSA-450513 | Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 1.165876e-01 | 0.933 |
R-HSA-110320 | Translesion Synthesis by POLH | 1.449620e-01 | 0.839 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 1.449620e-01 | 0.839 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 1.108018e-01 | 0.955 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 1.165876e-01 | 0.933 |
R-HSA-450604 | KSRP (KHSRP) binds and destabilizes mRNA | 1.223361e-01 | 0.912 |
R-HSA-9615933 | Postmitotic nuclear pore complex (NPC) reformation | 1.884947e-01 | 0.725 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 1.869654e-01 | 0.728 |
R-HSA-9663891 | Selective autophagy | 1.323365e-01 | 0.878 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 1.108018e-01 | 0.955 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 1.670100e-01 | 0.777 |
R-HSA-5689901 | Metalloprotease DUBs | 1.884947e-01 | 0.725 |
R-HSA-8984722 | Interleukin-35 Signalling | 9.911733e-02 | 1.004 |
R-HSA-1912420 | Pre-NOTCH Processing in Golgi | 1.449620e-01 | 0.839 |
R-HSA-77111 | Synthesis of Ketone Bodies | 1.505276e-01 | 0.822 |
R-HSA-70635 | Urea cycle | 1.884947e-01 | 0.725 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 1.683700e-01 | 0.774 |
R-HSA-9819196 | Zygotic genome activation (ZGA) | 1.560573e-01 | 0.807 |
R-HSA-389357 | CD28 dependent PI3K/Akt signaling | 1.937796e-01 | 0.713 |
R-HSA-9678110 | Attachment and Entry | 1.223361e-01 | 0.912 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 1.046299e-01 | 0.980 |
R-HSA-1640170 | Cell Cycle | 1.040098e-01 | 0.983 |
R-HSA-9694614 | Attachment and Entry | 1.615513e-01 | 0.792 |
R-HSA-74182 | Ketone body metabolism | 1.724334e-01 | 0.763 |
R-HSA-1257604 | PIP3 activates AKT signaling | 1.509980e-01 | 0.821 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 1.822879e-01 | 0.739 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 1.729889e-01 | 0.762 |
R-HSA-73864 | RNA Polymerase I Transcription | 1.087804e-01 | 0.963 |
R-HSA-9700206 | Signaling by ALK in cancer | 1.822879e-01 | 0.739 |
R-HSA-5688426 | Deubiquitination | 1.059375e-01 | 0.975 |
R-HSA-449836 | Other interleukin signaling | 1.449620e-01 | 0.839 |
R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | 1.724334e-01 | 0.763 |
R-HSA-9679191 | Potential therapeutics for SARS | 9.771238e-02 | 1.010 |
R-HSA-9856651 | MITF-M-dependent gene expression | 9.771238e-02 | 1.010 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 1.108721e-01 | 0.955 |
R-HSA-112315 | Transmission across Chemical Synapses | 1.862247e-01 | 0.730 |
R-HSA-2682334 | EPH-Ephrin signaling | 1.434003e-01 | 0.843 |
R-HSA-1266738 | Developmental Biology | 1.381920e-01 | 0.860 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 1.066996e-01 | 0.972 |
R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes | 1.025715e-01 | 0.989 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 1.029861e-01 | 0.987 |
R-HSA-168799 | Neurotoxicity of clostridium toxins | 1.670100e-01 | 0.777 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 1.209040e-01 | 0.918 |
R-HSA-5633007 | Regulation of TP53 Activity | 1.111043e-01 | 0.954 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 1.987313e-01 | 0.702 |
R-HSA-77387 | Insulin receptor recycling | 1.990303e-01 | 0.701 |
R-HSA-451326 | Activation of kainate receptors upon glutamate binding | 1.990303e-01 | 0.701 |
R-HSA-8940973 | RUNX2 regulates osteoblast differentiation | 1.990303e-01 | 0.701 |
R-HSA-9615710 | Late endosomal microautophagy | 2.042472e-01 | 0.690 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 2.042472e-01 | 0.690 |
R-HSA-418360 | Platelet calcium homeostasis | 2.042472e-01 | 0.690 |
R-HSA-68962 | Activation of the pre-replicative complex | 2.094305e-01 | 0.679 |
R-HSA-380972 | Energy dependent regulation of mTOR by LKB1-AMPK | 2.094305e-01 | 0.679 |
R-HSA-9006925 | Intracellular signaling by second messengers | 2.115249e-01 | 0.675 |
R-HSA-389958 | Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 2.145802e-01 | 0.668 |
R-HSA-2129379 | Molecules associated with elastic fibres | 2.145802e-01 | 0.668 |
R-HSA-9833109 | Evasion by RSV of host interferon responses | 2.145802e-01 | 0.668 |
R-HSA-9824446 | Viral Infection Pathways | 2.153995e-01 | 0.667 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 2.196968e-01 | 0.658 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 2.201201e-01 | 0.657 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 2.247804e-01 | 0.648 |
R-HSA-176187 | Activation of ATR in response to replication stress | 2.247804e-01 | 0.648 |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not kno... | 2.247804e-01 | 0.648 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 2.298311e-01 | 0.639 |
R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination | 2.298311e-01 | 0.639 |
R-HSA-199220 | Vitamin B5 (pantothenate) metabolism | 2.298311e-01 | 0.639 |
R-HSA-3247509 | Chromatin modifying enzymes | 2.305402e-01 | 0.637 |
R-HSA-5673000 | RAF activation | 2.348493e-01 | 0.629 |
R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery | 2.348493e-01 | 0.629 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 2.392914e-01 | 0.621 |
R-HSA-187687 | Signalling to ERKs | 2.398350e-01 | 0.620 |
R-HSA-917977 | Transferrin endocytosis and recycling | 2.398350e-01 | 0.620 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 2.398350e-01 | 0.620 |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | 2.447886e-01 | 0.611 |
R-HSA-8941326 | RUNX2 regulates bone development | 2.447886e-01 | 0.611 |
R-HSA-6804757 | Regulation of TP53 Degradation | 2.447886e-01 | 0.611 |
R-HSA-9843745 | Adipogenesis | 2.489121e-01 | 0.604 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 2.497102e-01 | 0.603 |
R-HSA-5689896 | Ovarian tumor domain proteases | 2.497102e-01 | 0.603 |
R-HSA-1566948 | Elastic fibre formation | 2.546000e-01 | 0.594 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 2.546000e-01 | 0.594 |
R-HSA-4839726 | Chromatin organization | 2.565394e-01 | 0.591 |
R-HSA-9725554 | Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | 2.594583e-01 | 0.586 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 2.594583e-01 | 0.586 |
R-HSA-163685 | Integration of energy metabolism | 2.633660e-01 | 0.579 |
R-HSA-9604323 | Negative regulation of NOTCH4 signaling | 2.642852e-01 | 0.578 |
R-HSA-202433 | Generation of second messenger molecules | 2.642852e-01 | 0.578 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 2.642852e-01 | 0.578 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 2.642852e-01 | 0.578 |
R-HSA-168249 | Innate Immune System | 2.646216e-01 | 0.577 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 2.688159e-01 | 0.571 |
R-HSA-5362768 | Hh mutants are degraded by ERAD | 2.690809e-01 | 0.570 |
R-HSA-110313 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA templa... | 2.690809e-01 | 0.570 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 2.690809e-01 | 0.570 |
R-HSA-913531 | Interferon Signaling | 2.704425e-01 | 0.568 |
R-HSA-199991 | Membrane Trafficking | 2.714095e-01 | 0.566 |
R-HSA-9664407 | Parasite infection | 2.730072e-01 | 0.564 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 2.730072e-01 | 0.564 |
R-HSA-9664417 | Leishmania phagocytosis | 2.730072e-01 | 0.564 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 2.738457e-01 | 0.562 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 2.754172e-01 | 0.560 |
R-HSA-379716 | Cytosolic tRNA aminoacylation | 2.785797e-01 | 0.555 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 2.785797e-01 | 0.555 |
R-HSA-5387390 | Hh mutants abrogate ligand secretion | 2.832832e-01 | 0.548 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 2.925991e-01 | 0.534 |
R-HSA-774815 | Nucleosome assembly | 2.925991e-01 | 0.534 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 2.925991e-01 | 0.534 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 2.925991e-01 | 0.534 |
R-HSA-166520 | Signaling by NTRKs | 2.946780e-01 | 0.531 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 2.972120e-01 | 0.527 |
R-HSA-75153 | Apoptotic execution phase | 2.972120e-01 | 0.527 |
R-HSA-9031628 | NGF-stimulated transcription | 3.063486e-01 | 0.514 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 3.063486e-01 | 0.514 |
R-HSA-389356 | Co-stimulation by CD28 | 3.063486e-01 | 0.514 |
R-HSA-73893 | DNA Damage Bypass | 3.108727e-01 | 0.507 |
R-HSA-532668 | N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 3.108727e-01 | 0.507 |
R-HSA-5658442 | Regulation of RAS by GAPs | 3.153675e-01 | 0.501 |
R-HSA-9711097 | Cellular response to starvation | 3.186544e-01 | 0.497 |
R-HSA-5358346 | Hedgehog ligand biogenesis | 3.198333e-01 | 0.495 |
R-HSA-5663205 | Infectious disease | 3.237945e-01 | 0.490 |
R-HSA-9931269 | AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 3.242703e-01 | 0.489 |
R-HSA-68949 | Orc1 removal from chromatin | 3.242703e-01 | 0.489 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 3.242703e-01 | 0.489 |
R-HSA-5339562 | Uptake and actions of bacterial toxins | 3.242703e-01 | 0.489 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 3.286786e-01 | 0.483 |
R-HSA-2467813 | Separation of Sister Chromatids | 3.329554e-01 | 0.478 |
R-HSA-72766 | Translation | 3.378123e-01 | 0.471 |
R-HSA-5578775 | Ion homeostasis | 3.417333e-01 | 0.466 |
R-HSA-9772572 | Early SARS-CoV-2 Infection Events | 3.502963e-01 | 0.456 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 3.542461e-01 | 0.451 |
R-HSA-191859 | snRNP Assembly | 3.545364e-01 | 0.450 |
R-HSA-194441 | Metabolism of non-coding RNA | 3.545364e-01 | 0.450 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 3.545364e-01 | 0.450 |
R-HSA-379724 | tRNA Aminoacylation | 3.587491e-01 | 0.445 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 3.589470e-01 | 0.445 |
R-HSA-168256 | Immune System | 3.606356e-01 | 0.443 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 3.670929e-01 | 0.435 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 3.712244e-01 | 0.430 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 3.712244e-01 | 0.430 |
R-HSA-2559583 | Cellular Senescence | 3.729749e-01 | 0.428 |
R-HSA-936837 | Ion transport by P-type ATPases | 3.753292e-01 | 0.426 |
R-HSA-8854518 | AURKA Activation by TPX2 | 3.834593e-01 | 0.416 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 3.834593e-01 | 0.416 |
R-HSA-5693606 | DNA Double Strand Break Response | 3.874849e-01 | 0.412 |
R-HSA-212165 | Epigenetic regulation of gene expression | 3.877416e-01 | 0.411 |
R-HSA-983712 | Ion channel transport | 3.937853e-01 | 0.405 |
R-HSA-112316 | Neuronal System | 3.955632e-01 | 0.403 |
R-HSA-75105 | Fatty acyl-CoA biosynthesis | 3.994063e-01 | 0.399 |
R-HSA-499943 | Interconversion of nucleotide di- and triphosphates | 4.072260e-01 | 0.390 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 4.072260e-01 | 0.390 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 4.110979e-01 | 0.386 |
R-HSA-69052 | Switching of origins to a post-replicative state | 4.110979e-01 | 0.386 |
R-HSA-597592 | Post-translational protein modification | 4.148703e-01 | 0.382 |
R-HSA-1236394 | Signaling by ERBB4 | 4.149447e-01 | 0.382 |
R-HSA-1222556 | ROS and RNS production in phagocytes | 4.149447e-01 | 0.382 |
R-HSA-380287 | Centrosome maturation | 4.187667e-01 | 0.378 |
R-HSA-8852135 | Protein ubiquitination | 4.187667e-01 | 0.378 |
R-HSA-917937 | Iron uptake and transport | 4.187667e-01 | 0.378 |
R-HSA-389948 | Co-inhibition by PD-1 | 4.187952e-01 | 0.378 |
R-HSA-5689603 | UCH proteinases | 4.225640e-01 | 0.374 |
R-HSA-6783783 | Interleukin-10 signaling | 4.300849e-01 | 0.366 |
R-HSA-4086400 | PCP/CE pathway | 4.300849e-01 | 0.366 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 4.375088e-01 | 0.359 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 4.375088e-01 | 0.359 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 4.411847e-01 | 0.355 |
R-HSA-73857 | RNA Polymerase II Transcription | 4.436698e-01 | 0.353 |
R-HSA-73894 | DNA Repair | 4.519469e-01 | 0.345 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 4.520704e-01 | 0.345 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 4.520704e-01 | 0.345 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 4.520704e-01 | 0.345 |
R-HSA-68882 | Mitotic Anaphase | 4.564034e-01 | 0.341 |
R-HSA-5653656 | Vesicle-mediated transport | 4.566582e-01 | 0.340 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 4.585731e-01 | 0.339 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 4.592105e-01 | 0.338 |
R-HSA-390466 | Chaperonin-mediated protein folding | 4.662585e-01 | 0.331 |
R-HSA-8951664 | Neddylation | 4.672024e-01 | 0.330 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 4.697483e-01 | 0.328 |
R-HSA-156902 | Peptide chain elongation | 4.697483e-01 | 0.328 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 4.766602e-01 | 0.322 |
R-HSA-373080 | Class B/2 (Secretin family receptors) | 4.766602e-01 | 0.322 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 4.778755e-01 | 0.321 |
R-HSA-391251 | Protein folding | 4.868612e-01 | 0.313 |
R-HSA-74752 | Signaling by Insulin receptor | 4.868612e-01 | 0.313 |
R-HSA-8953854 | Metabolism of RNA | 4.877047e-01 | 0.312 |
R-HSA-68867 | Assembly of the pre-replicative complex | 4.902175e-01 | 0.310 |
R-HSA-68886 | M Phase | 4.905034e-01 | 0.309 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 4.968651e-01 | 0.304 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 5.001566e-01 | 0.301 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 5.066758e-01 | 0.295 |
R-HSA-3214847 | HATs acetylate histones | 5.131108e-01 | 0.290 |
R-HSA-5619115 | Disorders of transmembrane transporters | 5.212646e-01 | 0.283 |
R-HSA-1483255 | PI Metabolism | 5.226077e-01 | 0.282 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 5.288368e-01 | 0.277 |
R-HSA-9833110 | RSV-host interactions | 5.319210e-01 | 0.274 |
R-HSA-5696398 | Nucleotide Excision Repair | 5.349853e-01 | 0.272 |
R-HSA-69278 | Cell Cycle, Mitotic | 5.352632e-01 | 0.271 |
R-HSA-418346 | Platelet homeostasis | 5.380298e-01 | 0.269 |
R-HSA-69239 | Synthesis of DNA | 5.410544e-01 | 0.267 |
R-HSA-74160 | Gene expression (Transcription) | 5.413933e-01 | 0.266 |
R-HSA-69002 | DNA Replication Pre-Initiation | 5.470451e-01 | 0.262 |
R-HSA-1280218 | Adaptive Immune System | 5.488610e-01 | 0.261 |
R-HSA-202403 | TCR signaling | 5.500113e-01 | 0.260 |
R-HSA-9675108 | Nervous system development | 5.566463e-01 | 0.254 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 5.587949e-01 | 0.253 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 5.616849e-01 | 0.251 |
R-HSA-909733 | Interferon alpha/beta signaling | 5.702428e-01 | 0.244 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 5.702428e-01 | 0.244 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 5.768146e-01 | 0.239 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 5.786352e-01 | 0.238 |
R-HSA-5693538 | Homology Directed Repair | 5.786352e-01 | 0.238 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 5.813964e-01 | 0.236 |
R-HSA-212436 | Generic Transcription Pathway | 5.816808e-01 | 0.235 |
R-HSA-9824443 | Parasitic Infection Pathways | 5.863022e-01 | 0.232 |
R-HSA-9658195 | Leishmania infection | 5.863022e-01 | 0.232 |
R-HSA-73886 | Chromosome Maintenance | 5.868652e-01 | 0.231 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 5.922632e-01 | 0.227 |
R-HSA-162909 | Host Interactions of HIV factors | 5.949360e-01 | 0.226 |
R-HSA-69206 | G1/S Transition | 6.002296e-01 | 0.222 |
R-HSA-449147 | Signaling by Interleukins | 6.114494e-01 | 0.214 |
R-HSA-195721 | Signaling by WNT | 6.163210e-01 | 0.210 |
R-HSA-5576891 | Cardiac conduction | 6.182231e-01 | 0.209 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 6.330060e-01 | 0.199 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 6.354141e-01 | 0.197 |
R-HSA-9948299 | Ribosome-associated quality control | 6.378066e-01 | 0.195 |
R-HSA-5358351 | Signaling by Hedgehog | 6.378066e-01 | 0.195 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 6.495375e-01 | 0.187 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 6.495375e-01 | 0.187 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 6.586506e-01 | 0.181 |
R-HSA-8957322 | Metabolism of steroids | 6.589968e-01 | 0.181 |
R-HSA-69242 | S Phase | 6.631187e-01 | 0.178 |
R-HSA-9758941 | Gastrulation | 6.653310e-01 | 0.177 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 6.697125e-01 | 0.174 |
R-HSA-69306 | DNA Replication | 6.740372e-01 | 0.171 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 6.740372e-01 | 0.171 |
R-HSA-73887 | Death Receptor Signaling | 6.761785e-01 | 0.170 |
R-HSA-162587 | HIV Life Cycle | 6.825190e-01 | 0.166 |
R-HSA-2408522 | Selenoamino acid metabolism | 6.968394e-01 | 0.157 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 7.158585e-01 | 0.145 |
R-HSA-5689880 | Ub-specific processing proteases | 7.161939e-01 | 0.145 |
R-HSA-422475 | Axon guidance | 7.181096e-01 | 0.144 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 7.199153e-01 | 0.143 |
R-HSA-611105 | Respiratory electron transport | 7.254070e-01 | 0.139 |
R-HSA-168255 | Influenza Infection | 7.272138e-01 | 0.138 |
R-HSA-392499 | Metabolism of proteins | 7.323421e-01 | 0.135 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 7.343238e-01 | 0.134 |
R-HSA-69275 | G2/M Transition | 7.395355e-01 | 0.131 |
R-HSA-453274 | Mitotic G2-G2/M phases | 7.429537e-01 | 0.129 |
R-HSA-5617833 | Cilium Assembly | 7.463273e-01 | 0.127 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 7.496572e-01 | 0.125 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 7.529437e-01 | 0.123 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 7.672120e-01 | 0.115 |
R-HSA-72172 | mRNA Splicing | 7.702702e-01 | 0.113 |
R-HSA-1643685 | Disease | 7.836133e-01 | 0.106 |
R-HSA-162906 | HIV Infection | 8.027038e-01 | 0.095 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 8.065851e-01 | 0.093 |
R-HSA-15869 | Metabolism of nucleotides | 8.141221e-01 | 0.089 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 8.201955e-01 | 0.086 |
R-HSA-9711123 | Cellular response to chemical stress | 8.496677e-01 | 0.071 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 8.555396e-01 | 0.068 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 8.602590e-01 | 0.065 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 8.630169e-01 | 0.064 |
R-HSA-1483257 | Phospholipid metabolism | 8.743582e-01 | 0.058 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 8.936179e-01 | 0.049 |
R-HSA-382551 | Transport of small molecules | 8.979634e-01 | 0.047 |
R-HSA-109582 | Hemostasis | 9.007427e-01 | 0.045 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 9.075138e-01 | 0.042 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 9.206763e-01 | 0.036 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 9.239634e-01 | 0.034 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 9.306022e-01 | 0.031 |
R-HSA-9824439 | Bacterial Infection Pathways | 9.337771e-01 | 0.030 |
R-HSA-8978868 | Fatty acid metabolism | 9.409011e-01 | 0.026 |
R-HSA-446203 | Asparagine N-linked glycosylation | 9.465532e-01 | 0.024 |
R-HSA-500792 | GPCR ligand binding | 9.826613e-01 | 0.008 |
R-HSA-9709957 | Sensory Perception | 9.904092e-01 | 0.004 |
R-HSA-556833 | Metabolism of lipids | 9.909574e-01 | 0.004 |
R-HSA-372790 | Signaling by GPCR | 9.972247e-01 | 0.001 |
R-HSA-1430728 | Metabolism | 9.999300e-01 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
COT |
0.803 | 0.090 | 2 | 0.791 |
CDC7 |
0.799 | 0.071 | 1 | 0.808 |
CLK3 |
0.799 | 0.155 | 1 | 0.819 |
TGFBR2 |
0.796 | 0.121 | -2 | 0.819 |
MOS |
0.796 | 0.075 | 1 | 0.798 |
CAMK1B |
0.796 | 0.042 | -3 | 0.747 |
PRPK |
0.795 | -0.097 | -1 | 0.733 |
GCN2 |
0.792 | -0.043 | 2 | 0.715 |
BMPR2 |
0.791 | 0.012 | -2 | 0.836 |
NLK |
0.790 | 0.016 | 1 | 0.747 |
CDKL1 |
0.790 | 0.026 | -3 | 0.684 |
ATR |
0.790 | 0.025 | 1 | 0.773 |
DSTYK |
0.789 | -0.010 | 2 | 0.774 |
HIPK4 |
0.789 | 0.062 | 1 | 0.764 |
PIM3 |
0.788 | -0.006 | -3 | 0.709 |
KIS |
0.788 | 0.086 | 1 | 0.638 |
NDR2 |
0.788 | 0.010 | -3 | 0.711 |
MLK1 |
0.788 | -0.001 | 2 | 0.743 |
RAF1 |
0.787 | -0.107 | 1 | 0.701 |
CDKL5 |
0.787 | 0.041 | -3 | 0.672 |
NUAK2 |
0.787 | 0.005 | -3 | 0.727 |
BMPR1B |
0.787 | 0.178 | 1 | 0.779 |
CAMLCK |
0.786 | 0.039 | -2 | 0.786 |
PKN3 |
0.786 | -0.006 | -3 | 0.701 |
RIPK3 |
0.786 | -0.043 | 3 | 0.722 |
RSK3 |
0.786 | 0.033 | -3 | 0.665 |
ERK5 |
0.786 | 0.000 | 1 | 0.704 |
SKMLCK |
0.785 | 0.031 | -2 | 0.777 |
ACVR2A |
0.785 | 0.187 | -2 | 0.816 |
GRK5 |
0.785 | -0.040 | -3 | 0.743 |
RSK2 |
0.785 | 0.033 | -3 | 0.661 |
ULK2 |
0.785 | -0.118 | 2 | 0.720 |
DAPK2 |
0.784 | 0.027 | -3 | 0.739 |
CAMK2G |
0.784 | -0.078 | 2 | 0.739 |
TBK1 |
0.784 | -0.099 | 1 | 0.554 |
ACVR2B |
0.784 | 0.187 | -2 | 0.812 |
NIK |
0.783 | -0.040 | -3 | 0.754 |
NEK6 |
0.783 | -0.018 | -2 | 0.838 |
TGFBR1 |
0.783 | 0.127 | -2 | 0.774 |
NEK7 |
0.782 | -0.082 | -3 | 0.681 |
IKKB |
0.782 | -0.141 | -2 | 0.685 |
ICK |
0.782 | 0.049 | -3 | 0.701 |
WNK1 |
0.782 | -0.051 | -2 | 0.762 |
GRK6 |
0.782 | 0.028 | 1 | 0.780 |
SRPK1 |
0.782 | 0.031 | -3 | 0.633 |
PDHK4 |
0.782 | -0.306 | 1 | 0.734 |
TSSK2 |
0.781 | 0.014 | -5 | 0.810 |
FAM20C |
0.781 | 0.073 | 2 | 0.550 |
PRKD1 |
0.781 | -0.010 | -3 | 0.681 |
MAPKAPK2 |
0.781 | 0.032 | -3 | 0.622 |
PKN2 |
0.781 | -0.018 | -3 | 0.718 |
CHAK2 |
0.781 | -0.038 | -1 | 0.728 |
ATM |
0.781 | 0.057 | 1 | 0.740 |
MTOR |
0.780 | -0.171 | 1 | 0.682 |
GRK1 |
0.780 | 0.026 | -2 | 0.703 |
PDHK1 |
0.780 | -0.212 | 1 | 0.702 |
SRPK2 |
0.780 | 0.044 | -3 | 0.577 |
AMPKA1 |
0.780 | -0.004 | -3 | 0.731 |
ALK4 |
0.780 | 0.090 | -2 | 0.788 |
P90RSK |
0.780 | -0.002 | -3 | 0.647 |
NUAK1 |
0.780 | 0.012 | -3 | 0.690 |
MAPKAPK3 |
0.780 | -0.021 | -3 | 0.658 |
IRE1 |
0.779 | -0.033 | 1 | 0.707 |
WNK3 |
0.779 | -0.124 | 1 | 0.690 |
IKKE |
0.779 | -0.135 | 1 | 0.550 |
MST4 |
0.779 | -0.015 | 2 | 0.802 |
PKCD |
0.779 | 0.028 | 2 | 0.735 |
BMPR1A |
0.779 | 0.199 | 1 | 0.775 |
TSSK1 |
0.778 | 0.029 | -3 | 0.741 |
IRE2 |
0.778 | 0.019 | 2 | 0.704 |
LATS2 |
0.778 | 0.013 | -5 | 0.765 |
P70S6KB |
0.778 | 0.002 | -3 | 0.690 |
PLK1 |
0.777 | 0.075 | -2 | 0.812 |
PRKD2 |
0.777 | 0.000 | -3 | 0.657 |
MLK3 |
0.777 | 0.018 | 2 | 0.682 |
CDK1 |
0.776 | 0.106 | 1 | 0.617 |
CLK4 |
0.776 | 0.074 | -3 | 0.659 |
GRK4 |
0.776 | -0.029 | -2 | 0.769 |
NDR1 |
0.776 | -0.052 | -3 | 0.705 |
PIM1 |
0.776 | 0.010 | -3 | 0.671 |
HUNK |
0.776 | -0.129 | 2 | 0.750 |
MARK4 |
0.776 | -0.077 | 4 | 0.851 |
IKKA |
0.775 | -0.031 | -2 | 0.687 |
ALK2 |
0.775 | 0.124 | -2 | 0.785 |
ANKRD3 |
0.775 | -0.068 | 1 | 0.722 |
ULK1 |
0.775 | -0.149 | -3 | 0.649 |
DLK |
0.774 | -0.099 | 1 | 0.748 |
CDK5 |
0.774 | 0.097 | 1 | 0.645 |
LATS1 |
0.774 | 0.073 | -3 | 0.698 |
SRPK3 |
0.774 | 0.019 | -3 | 0.622 |
GRK7 |
0.774 | 0.105 | 1 | 0.721 |
PKR |
0.774 | 0.045 | 1 | 0.745 |
TTBK2 |
0.773 | -0.094 | 2 | 0.638 |
AMPKA2 |
0.773 | -0.013 | -3 | 0.707 |
CLK1 |
0.773 | 0.074 | -3 | 0.653 |
MLK4 |
0.773 | 0.035 | 2 | 0.660 |
MYLK4 |
0.773 | 0.022 | -2 | 0.704 |
PLK3 |
0.772 | 0.097 | 2 | 0.694 |
MELK |
0.772 | -0.013 | -3 | 0.692 |
RIPK1 |
0.772 | -0.139 | 1 | 0.718 |
PRKD3 |
0.772 | -0.009 | -3 | 0.655 |
CAMK2D |
0.772 | -0.089 | -3 | 0.715 |
MLK2 |
0.772 | -0.088 | 2 | 0.720 |
BCKDK |
0.772 | -0.095 | -1 | 0.771 |
CAMK4 |
0.772 | -0.053 | -3 | 0.719 |
CDK8 |
0.771 | 0.032 | 1 | 0.631 |
PKACG |
0.771 | -0.020 | -2 | 0.672 |
CDK2 |
0.771 | 0.082 | 1 | 0.685 |
CAMK2A |
0.770 | -0.002 | 2 | 0.707 |
RSK4 |
0.770 | 0.035 | -3 | 0.632 |
PKG2 |
0.770 | 0.040 | -2 | 0.621 |
MSK2 |
0.770 | -0.017 | -3 | 0.630 |
DYRK2 |
0.770 | 0.036 | 1 | 0.686 |
NEK9 |
0.770 | -0.144 | 2 | 0.753 |
MNK2 |
0.770 | 0.001 | -2 | 0.726 |
P38A |
0.770 | 0.075 | 1 | 0.636 |
CAMK1G |
0.769 | 0.002 | -3 | 0.661 |
CDK7 |
0.769 | 0.021 | 1 | 0.625 |
PAK1 |
0.769 | 0.002 | -2 | 0.716 |
PKCG |
0.769 | -0.022 | 2 | 0.684 |
PKCH |
0.768 | -0.007 | 2 | 0.665 |
TLK2 |
0.768 | 0.027 | 1 | 0.705 |
MASTL |
0.768 | -0.259 | -2 | 0.734 |
PKCB |
0.768 | 0.004 | 2 | 0.668 |
CAMK2B |
0.768 | -0.011 | 2 | 0.700 |
AURC |
0.768 | 0.034 | -2 | 0.630 |
VRK2 |
0.767 | -0.082 | 1 | 0.786 |
PAK3 |
0.767 | -0.033 | -2 | 0.708 |
PHKG1 |
0.766 | -0.063 | -3 | 0.702 |
PKCA |
0.766 | -0.012 | 2 | 0.679 |
CHK1 |
0.766 | -0.013 | -3 | 0.722 |
CDK19 |
0.766 | 0.031 | 1 | 0.595 |
P38G |
0.766 | 0.079 | 1 | 0.530 |
PERK |
0.766 | 0.014 | -2 | 0.822 |
PAK6 |
0.766 | 0.024 | -2 | 0.655 |
ERK2 |
0.765 | 0.041 | 1 | 0.634 |
AKT2 |
0.765 | 0.033 | -3 | 0.607 |
P38B |
0.765 | 0.076 | 1 | 0.591 |
GRK2 |
0.765 | -0.008 | -2 | 0.683 |
CDK18 |
0.765 | 0.049 | 1 | 0.572 |
PKCZ |
0.765 | -0.026 | 2 | 0.699 |
TLK1 |
0.765 | 0.005 | -2 | 0.816 |
DYRK1A |
0.765 | 0.050 | 1 | 0.692 |
AURB |
0.764 | 0.028 | -2 | 0.629 |
AURA |
0.764 | 0.052 | -2 | 0.626 |
HRI |
0.764 | -0.020 | -2 | 0.834 |
CHAK1 |
0.764 | -0.093 | 2 | 0.663 |
JNK3 |
0.764 | 0.060 | 1 | 0.616 |
QIK |
0.764 | -0.124 | -3 | 0.731 |
CDK3 |
0.763 | 0.121 | 1 | 0.550 |
MEK1 |
0.763 | -0.154 | 2 | 0.761 |
SIK |
0.763 | -0.045 | -3 | 0.675 |
JNK2 |
0.763 | 0.070 | 1 | 0.573 |
CDK17 |
0.763 | 0.049 | 1 | 0.535 |
SMG1 |
0.762 | -0.055 | 1 | 0.728 |
PAK2 |
0.762 | -0.033 | -2 | 0.704 |
QSK |
0.762 | -0.058 | 4 | 0.842 |
MAPKAPK5 |
0.762 | -0.095 | -3 | 0.598 |
ERK1 |
0.762 | 0.054 | 1 | 0.570 |
MSK1 |
0.762 | -0.002 | -3 | 0.641 |
MARK2 |
0.762 | -0.042 | 4 | 0.784 |
MNK1 |
0.761 | -0.018 | -2 | 0.726 |
NIM1 |
0.761 | -0.143 | 3 | 0.713 |
CLK2 |
0.760 | 0.066 | -3 | 0.643 |
SMMLCK |
0.760 | 0.005 | -3 | 0.708 |
MARK3 |
0.760 | -0.051 | 4 | 0.797 |
PKACB |
0.760 | 0.033 | -2 | 0.632 |
DRAK1 |
0.760 | -0.069 | 1 | 0.682 |
IRAK4 |
0.760 | -0.036 | 1 | 0.712 |
SNRK |
0.760 | -0.160 | 2 | 0.623 |
P38D |
0.760 | 0.090 | 1 | 0.532 |
SSTK |
0.759 | -0.010 | 4 | 0.845 |
HIPK2 |
0.759 | 0.057 | 1 | 0.603 |
CDK13 |
0.759 | -0.002 | 1 | 0.603 |
HIPK1 |
0.759 | 0.031 | 1 | 0.690 |
CAMK1D |
0.759 | 0.019 | -3 | 0.619 |
PIM2 |
0.758 | -0.018 | -3 | 0.654 |
BRAF |
0.758 | -0.038 | -4 | 0.759 |
PLK4 |
0.758 | -0.062 | 2 | 0.604 |
YSK4 |
0.757 | -0.146 | 1 | 0.623 |
BRSK2 |
0.757 | -0.103 | -3 | 0.704 |
SGK3 |
0.757 | -0.020 | -3 | 0.661 |
DCAMKL2 |
0.757 | -0.025 | -3 | 0.704 |
PASK |
0.757 | -0.004 | -3 | 0.723 |
CDK14 |
0.757 | 0.036 | 1 | 0.596 |
PRKX |
0.756 | 0.043 | -3 | 0.601 |
GRK3 |
0.756 | 0.005 | -2 | 0.643 |
PLK2 |
0.756 | 0.181 | -3 | 0.789 |
WNK4 |
0.756 | -0.095 | -2 | 0.750 |
BRSK1 |
0.756 | -0.097 | -3 | 0.688 |
DCAMKL1 |
0.755 | -0.040 | -3 | 0.678 |
PINK1 |
0.755 | -0.128 | 1 | 0.725 |
IRAK1 |
0.755 | -0.094 | -1 | 0.657 |
MARK1 |
0.755 | -0.086 | 4 | 0.815 |
HIPK3 |
0.755 | 0.011 | 1 | 0.652 |
DYRK3 |
0.755 | 0.041 | 1 | 0.695 |
P70S6K |
0.755 | -0.028 | -3 | 0.620 |
PHKG2 |
0.754 | -0.058 | -3 | 0.706 |
EPHA6 |
0.754 | 0.206 | -1 | 0.834 |
CK1E |
0.754 | -0.062 | -3 | 0.461 |
CDK9 |
0.754 | -0.011 | 1 | 0.609 |
NEK2 |
0.754 | -0.179 | 2 | 0.719 |
MEKK1 |
0.754 | -0.105 | 1 | 0.679 |
CDK12 |
0.754 | 0.001 | 1 | 0.581 |
PRP4 |
0.754 | -0.040 | -3 | 0.552 |
ZAK |
0.753 | -0.098 | 1 | 0.681 |
DYRK4 |
0.753 | 0.037 | 1 | 0.612 |
CDK16 |
0.753 | 0.055 | 1 | 0.550 |
PKCT |
0.753 | -0.032 | 2 | 0.672 |
MEKK3 |
0.753 | -0.132 | 1 | 0.674 |
DAPK3 |
0.753 | 0.047 | -3 | 0.688 |
DNAPK |
0.752 | -0.036 | 1 | 0.611 |
JNK1 |
0.752 | 0.087 | 1 | 0.580 |
MEK5 |
0.752 | -0.227 | 2 | 0.738 |
DYRK1B |
0.752 | 0.024 | 1 | 0.623 |
AKT1 |
0.751 | 0.020 | -3 | 0.616 |
MEKK2 |
0.750 | -0.094 | 2 | 0.716 |
EEF2K |
0.750 | 0.037 | 3 | 0.786 |
TTBK1 |
0.750 | -0.124 | 2 | 0.576 |
PKCI |
0.749 | -0.044 | 2 | 0.690 |
PKCE |
0.749 | 0.008 | 2 | 0.673 |
CK2A2 |
0.749 | 0.083 | 1 | 0.654 |
PKACA |
0.749 | 0.022 | -2 | 0.595 |
NEK5 |
0.749 | -0.147 | 1 | 0.704 |
CK1A2 |
0.749 | -0.041 | -3 | 0.420 |
CAMK1A |
0.748 | 0.022 | -3 | 0.584 |
CK1D |
0.747 | -0.062 | -3 | 0.412 |
DAPK1 |
0.747 | 0.028 | -3 | 0.678 |
ERK7 |
0.747 | -0.005 | 2 | 0.491 |
CHK2 |
0.746 | -0.006 | -3 | 0.563 |
TAO3 |
0.746 | -0.073 | 1 | 0.665 |
NEK8 |
0.745 | -0.138 | 2 | 0.739 |
MST3 |
0.745 | -0.104 | 2 | 0.755 |
EPHB4 |
0.744 | 0.156 | -1 | 0.819 |
VRK1 |
0.744 | -0.017 | 2 | 0.785 |
CAMKK1 |
0.743 | -0.166 | -2 | 0.703 |
PDHK3_TYR |
0.743 | -0.034 | 4 | 0.825 |
CDK10 |
0.743 | 0.015 | 1 | 0.586 |
TTK |
0.743 | 0.162 | -2 | 0.837 |
TXK |
0.742 | 0.206 | 1 | 0.761 |
CDK6 |
0.742 | 0.031 | 1 | 0.568 |
PKN1 |
0.742 | -0.045 | -3 | 0.632 |
CDK4 |
0.742 | 0.032 | 1 | 0.575 |
PAK5 |
0.741 | -0.025 | -2 | 0.619 |
PAK4 |
0.741 | -0.010 | -2 | 0.639 |
MPSK1 |
0.741 | -0.093 | 1 | 0.628 |
AKT3 |
0.741 | 0.023 | -3 | 0.541 |
TAO2 |
0.741 | -0.117 | 2 | 0.770 |
BMPR2_TYR |
0.740 | 0.004 | -1 | 0.760 |
GSK3B |
0.740 | -0.069 | 4 | 0.313 |
SGK1 |
0.739 | 0.012 | -3 | 0.534 |
MAK |
0.739 | 0.070 | -2 | 0.720 |
MRCKB |
0.739 | 0.009 | -3 | 0.655 |
CAMKK2 |
0.739 | -0.173 | -2 | 0.714 |
EPHA4 |
0.738 | 0.098 | 2 | 0.706 |
CK1G1 |
0.738 | -0.096 | -3 | 0.440 |
PDK1 |
0.738 | -0.130 | 1 | 0.667 |
MST2 |
0.738 | -0.081 | 1 | 0.653 |
EPHB3 |
0.738 | 0.144 | -1 | 0.837 |
LIMK2_TYR |
0.738 | -0.015 | -3 | 0.741 |
MOK |
0.738 | 0.031 | 1 | 0.700 |
CK2A1 |
0.737 | 0.051 | 1 | 0.636 |
EPHB2 |
0.737 | 0.165 | -1 | 0.817 |
TESK1_TYR |
0.737 | -0.144 | 3 | 0.817 |
PDHK1_TYR |
0.737 | -0.051 | -1 | 0.790 |
LRRK2 |
0.737 | -0.144 | 2 | 0.762 |
NEK11 |
0.737 | -0.242 | 1 | 0.641 |
BUB1 |
0.737 | 0.003 | -5 | 0.755 |
FER |
0.737 | 0.064 | 1 | 0.797 |
EPHB1 |
0.737 | 0.118 | 1 | 0.773 |
GAK |
0.737 | -0.130 | 1 | 0.685 |
PKMYT1_TYR |
0.737 | -0.111 | 3 | 0.808 |
MAP2K4_TYR |
0.736 | -0.139 | -1 | 0.745 |
STK33 |
0.736 | -0.128 | 2 | 0.585 |
ROCK2 |
0.736 | 0.013 | -3 | 0.675 |
MAP2K6_TYR |
0.736 | -0.088 | -1 | 0.755 |
TYRO3 |
0.736 | 0.005 | 3 | 0.768 |
CSF1R |
0.735 | 0.030 | 3 | 0.768 |
DDR1 |
0.735 | -0.010 | 4 | 0.796 |
ROS1 |
0.735 | -0.013 | 3 | 0.752 |
MRCKA |
0.735 | -0.007 | -3 | 0.656 |
MST1R |
0.735 | -0.049 | 3 | 0.785 |
DMPK1 |
0.735 | 0.046 | -3 | 0.668 |
PKG1 |
0.734 | 0.005 | -2 | 0.552 |
ABL2 |
0.734 | 0.052 | -1 | 0.767 |
MAP2K7_TYR |
0.734 | -0.248 | 2 | 0.765 |
MAP3K15 |
0.734 | -0.155 | 1 | 0.643 |
EPHA7 |
0.734 | 0.120 | 2 | 0.708 |
PINK1_TYR |
0.734 | -0.168 | 1 | 0.748 |
GSK3A |
0.734 | -0.050 | 4 | 0.315 |
ITK |
0.733 | 0.081 | -1 | 0.746 |
SRMS |
0.733 | 0.097 | 1 | 0.786 |
RET |
0.733 | -0.056 | 1 | 0.704 |
PDHK4_TYR |
0.733 | -0.120 | 2 | 0.773 |
SBK |
0.733 | -0.007 | -3 | 0.507 |
YES1 |
0.732 | 0.076 | -1 | 0.789 |
ABL1 |
0.732 | 0.053 | -1 | 0.765 |
LOK |
0.732 | -0.107 | -2 | 0.710 |
MINK |
0.732 | -0.117 | 1 | 0.627 |
TAK1 |
0.732 | -0.171 | 1 | 0.687 |
MEKK6 |
0.732 | -0.188 | 1 | 0.671 |
RIPK2 |
0.732 | -0.195 | 1 | 0.596 |
INSRR |
0.731 | 0.016 | 3 | 0.742 |
TEK |
0.731 | -0.006 | 3 | 0.732 |
HCK |
0.731 | 0.048 | -1 | 0.781 |
BLK |
0.731 | 0.114 | -1 | 0.803 |
ALPHAK3 |
0.731 | 0.035 | -1 | 0.678 |
LCK |
0.731 | 0.081 | -1 | 0.788 |
TNIK |
0.731 | -0.082 | 3 | 0.797 |
NEK4 |
0.730 | -0.238 | 1 | 0.641 |
LKB1 |
0.730 | -0.217 | -3 | 0.665 |
TEC |
0.730 | 0.120 | -1 | 0.732 |
SLK |
0.729 | -0.105 | -2 | 0.671 |
LIMK1_TYR |
0.729 | -0.158 | 2 | 0.767 |
GCK |
0.729 | -0.143 | 1 | 0.633 |
PDGFRB |
0.729 | -0.015 | 3 | 0.771 |
HGK |
0.729 | -0.140 | 3 | 0.790 |
FRK |
0.728 | 0.087 | -1 | 0.812 |
FLT3 |
0.728 | -0.013 | 3 | 0.755 |
NEK1 |
0.728 | -0.197 | 1 | 0.676 |
KIT |
0.728 | -0.024 | 3 | 0.771 |
MST1 |
0.728 | -0.133 | 1 | 0.635 |
EPHA8 |
0.727 | 0.110 | -1 | 0.825 |
FGFR2 |
0.727 | -0.038 | 3 | 0.757 |
PTK2B |
0.727 | 0.111 | -1 | 0.766 |
FGR |
0.726 | -0.051 | 1 | 0.720 |
JAK2 |
0.726 | -0.124 | 1 | 0.693 |
TYK2 |
0.726 | -0.163 | 1 | 0.687 |
KDR |
0.726 | -0.037 | 3 | 0.729 |
ALK |
0.726 | 0.008 | 3 | 0.725 |
FGFR1 |
0.726 | -0.037 | 3 | 0.737 |
AXL |
0.726 | 0.008 | 3 | 0.743 |
MEK2 |
0.725 | -0.228 | 2 | 0.729 |
MERTK |
0.725 | 0.011 | 3 | 0.743 |
OSR1 |
0.725 | -0.033 | 2 | 0.727 |
JAK3 |
0.724 | -0.090 | 1 | 0.700 |
MET |
0.724 | -0.011 | 3 | 0.757 |
PDGFRA |
0.724 | -0.062 | 3 | 0.775 |
TNK2 |
0.724 | -0.035 | 3 | 0.727 |
HASPIN |
0.724 | -0.040 | -1 | 0.535 |
BMX |
0.724 | 0.020 | -1 | 0.675 |
ROCK1 |
0.724 | -0.002 | -3 | 0.654 |
EPHA5 |
0.724 | 0.097 | 2 | 0.686 |
EPHA3 |
0.724 | 0.008 | 2 | 0.685 |
TNNI3K_TYR |
0.723 | -0.013 | 1 | 0.729 |
FYN |
0.722 | 0.093 | -1 | 0.774 |
LTK |
0.722 | -0.009 | 3 | 0.740 |
BTK |
0.722 | -0.018 | -1 | 0.719 |
YSK1 |
0.722 | -0.146 | 2 | 0.727 |
NEK3 |
0.722 | -0.173 | 1 | 0.626 |
CRIK |
0.722 | -0.008 | -3 | 0.608 |
EPHA1 |
0.721 | 0.009 | 3 | 0.738 |
PTK6 |
0.720 | -0.008 | -1 | 0.692 |
LYN |
0.720 | 0.059 | 3 | 0.709 |
ERBB2 |
0.720 | -0.049 | 1 | 0.688 |
KHS1 |
0.719 | -0.138 | 1 | 0.608 |
YANK3 |
0.719 | -0.052 | 2 | 0.397 |
PBK |
0.719 | -0.130 | 1 | 0.571 |
HPK1 |
0.719 | -0.201 | 1 | 0.611 |
FLT1 |
0.719 | -0.045 | -1 | 0.780 |
DDR2 |
0.718 | 0.028 | 3 | 0.730 |
TNK1 |
0.718 | -0.092 | 3 | 0.746 |
KHS2 |
0.718 | -0.110 | 1 | 0.621 |
FGFR3 |
0.718 | -0.065 | 3 | 0.745 |
NTRK2 |
0.717 | -0.048 | 3 | 0.751 |
INSR |
0.717 | -0.046 | 3 | 0.729 |
FLT4 |
0.717 | -0.070 | 3 | 0.738 |
PTK2 |
0.717 | 0.052 | -1 | 0.737 |
MATK |
0.716 | -0.033 | -1 | 0.702 |
SRC |
0.716 | 0.075 | -1 | 0.786 |
NTRK1 |
0.716 | -0.074 | -1 | 0.769 |
EPHA2 |
0.714 | 0.046 | -1 | 0.765 |
WEE1_TYR |
0.714 | -0.088 | -1 | 0.658 |
MYO3B |
0.714 | -0.090 | 2 | 0.733 |
BIKE |
0.714 | -0.087 | 1 | 0.535 |
EGFR |
0.714 | 0.004 | 1 | 0.634 |
CSK |
0.714 | -0.006 | 2 | 0.710 |
NTRK3 |
0.714 | -0.047 | -1 | 0.738 |
SYK |
0.713 | 0.058 | -1 | 0.738 |
CK1A |
0.713 | -0.076 | -3 | 0.330 |
MYO3A |
0.712 | -0.093 | 1 | 0.653 |
JAK1 |
0.710 | -0.134 | 1 | 0.610 |
ERBB4 |
0.709 | 0.024 | 1 | 0.665 |
FGFR4 |
0.708 | -0.028 | -1 | 0.726 |
NEK10_TYR |
0.708 | -0.177 | 1 | 0.549 |
MUSK |
0.707 | -0.047 | 1 | 0.584 |
ASK1 |
0.707 | -0.221 | 1 | 0.637 |
TAO1 |
0.707 | -0.150 | 1 | 0.579 |
STLK3 |
0.703 | -0.162 | 1 | 0.632 |
IGF1R |
0.703 | -0.069 | 3 | 0.685 |
FES |
0.703 | -0.005 | -1 | 0.677 |
AAK1 |
0.695 | -0.064 | 1 | 0.429 |
CK1G3 |
0.689 | -0.074 | -3 | 0.293 |
YANK2 |
0.688 | -0.076 | 2 | 0.413 |
ZAP70 |
0.682 | -0.060 | -1 | 0.634 |
CK1G2 |
0.680 | -0.039 | -3 | 0.373 |